MP8 |
Function assay |
13 nM |
24 hrs |
Inhibition of alpha-tubulin polymerization in human human MP8 cells assessed as increase in ratio of soluble to polymerized tubulin fraction at 13 nM after 24 hrs by western blot analysis |
27643641 |
STO |
Function assay |
2 nM |
24 hrs |
Inhibition of alpha-tubulin polymerization in human human STO cells assessed as increase in ratio of soluble to polymerized tubulin fraction at 2 nM after 24 hrs by western blot analysis |
27643641 |
HTR-8/SVneo |
Cell viability assay |
0.01-100 μM |
48 h |
vinorelbine significantly reduced HTR-8/svneo cell viability in a dose-dependent manner, down to a concentration of 1 μM. |
29429891 |
JEG3 |
Cell viability assay |
0.01-100 μM |
48 h |
vinorelbine significantly reduced JEG3 cell viability in a dose-dependent manner, down to a concentration of 0.1 μM. |
29429891 |
MP8 |
Cell cycle assay |
|
48 to 72 hrs |
Cell cycle arrest in human MP8 cells assessed as accumulation at G2/M phase at antiproliferative IC50 after 48 to 72 hrs by propidium iodide staining based flow cytometry |
27643641 |
STO |
Cell cycle assay |
|
48 to 72 hrs |
Cell cycle arrest in human STO cells assessed as accumulation at G2/M phase at antiproliferative IC50 after 48 to 72 hrs by propidium iodide staining based flow cytometry |
27643641 |
U2OS |
Function assay |
|
72 hrs |
Inhibition of tubulin polymerization in human U2OS cells at cytotoxic IC50 level after 72 hrs by Western blotting method |
25768699 |
U2OS |
Apoptosis assay |
|
72 hrs |
Induction of apoptosis in human U2OS cells assessed as increase in caspase-3 catalytic activity at cytotoxic IC50 level after 72 hrs |
25768699 |
A549 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human A549 cells after 48 hrs by MTT assay, IC50 = 26.1 μM. |
20462230 |
HepG2 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay, IC50 = 23.12 μM. |
26420067 |
MCF7 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay, IC50 = 17.2 μM. |
20462230 |
HL60 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay, IC50 = 11.47 μM. |
26420067 |
BESM |
Antitrypanosomal assay |
|
88 hrs |
Antitrypanosomal activity against Trypanosoma cruzi amastigotes infected in BESM cells measured after 88 hrs postinfection by HTS assay, EC50 = 10 μM. |
20547819 |
NCI/ADR-RES |
Growth inhibition assay |
|
96 hrs |
Growth inhibition of human NCI/ADR-RES cells after 96 hrs by trypan blue exclusion assay, IC50 = 5 μM. |
29730191 |
NCI-ADR-RES |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against Pgp overexpressing human NCI-ADR-RES cells assessed as growth inhibition after 48 hrs by SRB assay, IC50 = 5 μM. |
26132075 |
NCI/ADR-RES |
Cytotoxicity assay |
|
96 hrs |
Cytotoxicity against human NCI/ADR-RES cells assessed as growth inhibition after 96 hrs by Giemsa staining-based light microscopy, IC50 = 5 μM. |
25025991 |
NCI-ADR-RES |
Growth inhibition assay |
|
96 hrs |
Growth inhibition of doxorubicin-resistant human NCI-ADR-RES cells overexpressing P-glycoprotein after 96 hrs, IC50 = 5 μM. |
22044164 |
SMMC7721 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human SMMC7721 cells after 48 hrs by MTT assay, IC50 = 4.7 μM. |
20462230 |
HCT116/VM46 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human vinblastine-resistant HCT116/VM46 cells assessed as growth inhibition after 72 hrs by phosphatase assay, IC50 = 0.6 μM. |
23252481 |
K562R |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against doxorubicin-resistant human K562R cells incubated for 72 hrs by CellTiter 96 aqueous one solution reagent based assay, IC50 = 0.41 μM. |
27753480 |
OVCAR8 |
Growth inhibition assay |
|
96 hrs |
Growth inhibition of human OVCAR8 cells after 96 hrs by trypan blue exclusion assay, IC50 = 0.3 μM. |
29730191 |
OVCAR8 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human OVCAR8 cells assessed as growth inhibition after 48 hrs by SRB assay, IC50 = 0.3 μM. |
26132075 |
OVCAR8 |
Cytotoxicity assay |
|
96 hrs |
Cytotoxicity against human OVCAR8 cells assessed as growth inhibition after 96 hrs by Giemsa staining-based light microscopy, IC50 = 0.3 μM. |
25025991 |
OVCAR8 |
Growth inhibition assay |
|
96 hrs |
Growth inhibition of human OVCAR8 cells overexpressing P-glycoprotein after 96 hrs, IC50 = 0.3 μM. |
22044164 |
HCT116 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by phosphatase assay, IC50 = 0.075 μM. |
23252481 |
MCF7 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay, IC50 = 0.07 μM. |
19743863 |
HeLa |
Function assay |
|
4.5 hrs |
Inhibition of Ebolavirus glycoprotein/matrix protein VP40 entry in human HeLa cells after 4.5 hrs beta-lactamase reporter assay, IC50 = 0.066 μM. |
29624387 |
L1210 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against mouse L1210 cells assessed as growth inhibition after 72 hrs by phosphatase assay, IC50 = 0.065 μM. |
23252481 |
A549 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay, IC50 = 0.0646 μM. |
21480626 |
A431 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human A431 cells after 72 hrs by sulforhodamine B assay, IC50 = 0.06 μM. |
21480626 |
HL60 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay, IC50 = 0.06 μM. |
20462230 |
A549 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human A549 cells after 72 hrs by SRB assay, IC50 = 0.049 μM. |
17544278 |
NCI-H460 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human NCI-H460 cells after 72 hrs by sulforhodamine B assay, IC50 = 0.0437 μM. |
21480626 |
KB |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human KB cells after 72 hrs, IC50 = 0.04 μM. |
19072542 |
A549 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human A549 cells after 72 hrs by SRB assay, IC50 = 0.0369 μM. |
18771244 |
HCT116 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HCT116 cells after 72 hrs, IC50 = 0.035 μM. |
24871162 |
HCT116 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HCT116 cells after 72 hrs by resazurin assay, IC50 = 0.035 μM. |
23822556 |
HeLa |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay, IC50 = 0.0269 μM. |
18771244 |
SKOV3 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human SKOV3 cells after 72 hrs by sulforhodamine B assay, IC50 = 0.0267 μM. |
21480626 |
HeLa |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HeLa cells after 72 hrs by SRB assay, IC50 = 0.026 μM. |
17544278 |
K562 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human K562 cells after 72 hrs by resazurin assay, IC50 = 0.02 μM. |
23822556 |
HCT116 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs, IC50 = 0.015 μM. |
25804719 |
HCT116 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human HCT116 cells after 72 hrs by resazurin-based fluorimetric assay, IC50 = 0.015 μM. |
24901800 |
HT-29 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human HT-29 cells after 72 hrs by sulforhodamine B assay, IC50 = 0.0119 μM. |
21480626 |
A549 |
Cytotoxicity assay |
|
24 to 72 hrs |
Cytotoxicity against human A549 cells after 24 to 72 hrs by MTT assay, IC50 = 0.009 μM. |
23107481 |
K562 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human K562 cells after 72 hrs by resazurin-based fluorimetric assay, IC50 = 0.006 μM. |
24901800 |
K562 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human K562 cells assessed as inhibition of cell proliferation after 72 hrs, IC50 = 0.006 μM. |
25804719 |
KB |
Cell cycle assay |
|
24 hrs |
Cell cycle arrest in human KB cells assessed as accumulation of cells at G2/M phase after 24 hrs by propidium iodide-based FACScan, EC50 = 0.006 μM. |
21480626 |
MCF7 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MCF7 cells after 72 hrs, IC50 = 0.004 μM. |
24871162 |
U87 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human U87 cells assessed as inhibition of cell proliferation after 72 hrs, IC50 = 0.0035 μM. |
25804719 |
K562 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human K562 cells after 72 hrs, IC50 = 0.0035 μM. |
24871162 |
K562 |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human K562 cells incubated for 72 hrs by CellTiter 96 aqueous one solution reagent based assay, IC50 = 0.003 μM. |
27753480 |
U87 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human U87 cells after 72 hrs, IC50 = 0.002 μM. |
24871162 |
U87MG |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human U87MG cells after 72 hrs by resazurin assay, IC50 = 0.002 μM. |
23822556 |
KB |
Cytotoxicity assay |
|
72 hrs |
Cytotoxicity against human KB cells after 72 hrs, IC50 = 0.001 μM. |
19072542 |
SCC114 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against exponentially growing adherent human SCC114 cells assessed as inhibition of cell proliferation after 72 hrs by luminescence detection based ATPlite assay, IC50 = 0.00007 μM. |
25872984 |
IST-MES1 |
Growth inhibition assay |
|
|
Inhibition of human IST-MES1 cell growth in a cell viability assay, IC50 = 0.53233 μM. |
SANGER |
BHT-101 |
Growth inhibition assay |
|
|
Inhibition of human BHT-101 cell growth in a cell viability assay, IC50 = 0.51311 μM. |
SANGER |
Calu-1 |
Growth inhibition assay |
|
|
Inhibition of human Calu-1 cell growth in a cell viability assay, IC50 = 0.51639 μM. |
SANGER |
COLO-320-HSR |
Growth inhibition assay |
|
|
Inhibition of human COLO-320-HSR cell growth in a cell viability assay, IC50 = 0.52165 μM. |
SANGER |
SHP-77 |
Growth inhibition assay |
|
|
Inhibition of human SHP-77 cell growth in a cell viability assay, IC50 = 0.50808 μM. |
SANGER |
D-263MG |
Growth inhibition assay |
|
|
Inhibition of human D-263MG cell growth in a cell viability assay, IC50 = 0.50551 μM. |
SANGER |
TE-12 |
Growth inhibition assay |
|
|
Inhibition of human TE-12 cell growth in a cell viability assay, IC50 = 0.49653 μM. |
SANGER |
SW1783 |
Growth inhibition assay |
|
|
Inhibition of human SW1783 cell growth in a cell viability assay, IC50 = 0.49239 μM. |
SANGER |
LS-513 |
Growth inhibition assay |
|
|
Inhibition of human LS-513 cell growth in a cell viability assay, IC50 = 0.48288 μM. |
SANGER |
KY821 |
Growth inhibition assay |
|
|
Inhibition of human KY821 cell growth in a cell viability assay, IC50 = 0.47276 μM. |
SANGER |
SF126 |
Growth inhibition assay |
|
|
Inhibition of human SF126 cell growth in a cell viability assay, IC50 = 0.45923 μM. |
SANGER |
EB-3 |
Growth inhibition assay |
|
|
Inhibition of human EB-3 cell growth in a cell viability assay, IC50 = 0.44051 μM. |
SANGER |
HCC1143 |
Growth inhibition assay |
|
|
Inhibition of human HCC1143 cell growth in a cell viability assay, IC50 = 0.43816 μM. |
SANGER |
RL |
Growth inhibition assay |
|
|
Inhibition of human RL cell growth in a cell viability assay, IC50 = 0.41513 μM. |
SANGER |
SW1463 |
Growth inhibition assay |
|
|
Inhibition of human SW1463 cell growth in a cell viability assay, IC50 = 0.40946 μM. |
SANGER |
DMS-114 |
Growth inhibition assay |
|
|
Inhibition of human DMS-114 cell growth in a cell viability assay, IC50 = 0.40102 μM. |
SANGER |
T47D |
Growth inhibition assay |
|
|
Inhibition of human T47D cell growth in a cell viability assay, IC50 = 0.40041 μM. |
SANGER |
HCC1419 |
Growth inhibition assay |
|
|
Inhibition of human HCC1419 cell growth in a cell viability assay, IC50 = 0.39656 μM. |
SANGER |
SW837 |
Growth inhibition assay |
|
|
Inhibition of human SW837 cell growth in a cell viability assay, IC50 = 0.37965 μM. |
SANGER |
S-117 |
Growth inhibition assay |
|
|
Inhibition of human S-117 cell growth in a cell viability assay, IC50 = 0.36822 μM. |
SANGER |
LB2241-RCC |
Growth inhibition assay |
|
|
Inhibition of human LB2241-RCC cell growth in a cell viability assay, IC50 = 0.35241 μM. |
SANGER |
DMS-153 |
Growth inhibition assay |
|
|
Inhibition of human DMS-153 cell growth in a cell viability assay, IC50 = 0.35024 μM. |
SANGER |
MPP-89 |
Growth inhibition assay |
|
|
Inhibition of human MPP-89 cell growth in a cell viability assay, IC50 = 0.34294 μM. |
SANGER |
RT4 |
Growth inhibition assay |
|
|
Inhibition of human RT4 cell growth in a cell viability assay, IC50 = 0.33062 μM. |
SANGER |
NCI-H2196 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2196 cell growth in a cell viability assay, IC50 = 0.32849 μM. |
SANGER |
CPC-N |
Growth inhibition assay |
|
|
Inhibition of human CPC-N cell growth in a cell viability assay, IC50 = 0.31876 μM. |
SANGER |
EFE-184 |
Growth inhibition assay |
|
|
Inhibition of human EFE-184 cell growth in a cell viability assay, IC50 = 0.31668 μM. |
SANGER |
LP-1 |
Growth inhibition assay |
|
|
Inhibition of human LP-1 cell growth in a cell viability assay, IC50 = 0.31132 μM. |
SANGER |
FTC-133 |
Growth inhibition assay |
|
|
Inhibition of human FTC-133 cell growth in a cell viability assay, IC50 = 0.30939 μM. |
SANGER |
LB996-RCC |
Growth inhibition assay |
|
|
Inhibition of human LB996-RCC cell growth in a cell viability assay, IC50 = 0.30883 μM. |
SANGER |
MDA-MB-134-VI |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-134-VI cell growth in a cell viability assay, IC50 = 0.30194 μM. |
SANGER |
JVM-3 |
Growth inhibition assay |
|
|
Inhibition of human JVM-3 cell growth in a cell viability assay, IC50 = 0.29206 μM. |
SANGER |
EKVX |
Growth inhibition assay |
|
|
Inhibition of human EKVX cell growth in a cell viability assay, IC50 = 0.28708 μM. |
SANGER |
T-24 |
Growth inhibition assay |
|
|
Inhibition of human T-24 cell growth in a cell viability assay, IC50 = 0.28425 μM. |
SANGER |
SiHa |
Growth inhibition assay |
|
|
Inhibition of human SiHa cell growth in a cell viability assay, IC50 = 0.28127 μM. |
SANGER |
MDA-MB-175-VII |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-175-VII cell growth in a cell viability assay, IC50 = 0.28065 μM. |
SANGER |
EVSA-T |
Growth inhibition assay |
|
|
Inhibition of human EVSA-T cell growth in a cell viability assay, IC50 = 0.27519 μM. |
SANGER |
EW-24 |
Growth inhibition assay |
|
|
Inhibition of human EW-24 cell growth in a cell viability assay, IC50 = 0.27474 μM. |
SANGER |
MKN7 |
Growth inhibition assay |
|
|
Inhibition of human MKN7 cell growth in a cell viability assay, IC50 = 0.25838 μM. |
SANGER |
HuP-T3 |
Growth inhibition assay |
|
|
Inhibition of human HuP-T3 cell growth in a cell viability assay, IC50 = 0.25614 μM. |
SANGER |
SK-N-DZ |
Growth inhibition assay |
|
|
Inhibition of human SK-N-DZ cell growth in a cell viability assay, IC50 = 0.24904 μM. |
SANGER |
LN-405 |
Growth inhibition assay |
|
|
Inhibition of human LN-405 cell growth in a cell viability assay, IC50 = 0.24504 μM. |
SANGER |
MHH-CALL-2 |
Growth inhibition assay |
|
|
Inhibition of human MHH-CALL-2 cell growth in a cell viability assay, IC50 = 0.24193 μM. |
SANGER |
COLO-792 |
Growth inhibition assay |
|
|
Inhibition of human COLO-792 cell growth in a cell viability assay, IC50 = 0.22044 μM. |
SANGER |
NCI-H727 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H727 cell growth in a cell viability assay, IC50 = 0.22454 μM. |
SANGER |
YT |
Growth inhibition assay |
|
|
Inhibition of human YT cell growth in a cell viability assay, IC50 = 0.21854 μM. |
SANGER |
LS-1034 |
Growth inhibition assay |
|
|
Inhibition of human LS-1034 cell growth in a cell viability assay, IC50 = 0.21618 μM. |
SANGER |
LB2518-MEL |
Growth inhibition assay |
|
|
Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50 = 0.21062 μM. |
SANGER |
C3A |
Growth inhibition assay |
|
|
Inhibition of human C3A cell growth in a cell viability assay, IC50 = 0.20959 μM. |
SANGER |
BB49-HNC |
Growth inhibition assay |
|
|
Inhibition of human BB49-HNC cell growth in a cell viability assay, IC50 = 0.20972 μM. |
SANGER |
MDA-MB-453 |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-453 cell growth in a cell viability assay, IC50 = 0.19951 μM. |
SANGER |
BOKU |
Growth inhibition assay |
|
|
Inhibition of human BOKU cell growth in a cell viability assay, IC50 = 0.19522 μM. |
SANGER |
LU-165 |
Growth inhibition assay |
|
|
Inhibition of human LU-165 cell growth in a cell viability assay, IC50 = 0.19534 μM. |
SANGER |
GB-1 |
Growth inhibition assay |
|
|
Inhibition of human GB-1 cell growth in a cell viability assay, IC50 = 0.18959 μM. |
SANGER |
ECC4 |
Growth inhibition assay |
|
|
Inhibition of human ECC4 cell growth in a cell viability assay, IC50 = 0.18919 μM. |
SANGER |
COLO-678 |
Growth inhibition assay |
|
|
Inhibition of human COLO-678 cell growth in a cell viability assay, IC50 = 0.18905 μM. |
SANGER |
NCI-H1522 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1522 cell growth in a cell viability assay, IC50 = 0.18527 μM. |
SANGER |
EW-3 |
Growth inhibition assay |
|
|
Inhibition of human EW-3 cell growth in a cell viability assay, IC50 = 0.18223 μM. |
SANGER |
SNU-449 |
Growth inhibition assay |
|
|
Inhibition of human SNU-449 cell growth in a cell viability assay, IC50 = 0.1738 μM. |
SANGER |
KLE |
Growth inhibition assay |
|
|
Inhibition of human KLE cell growth in a cell viability assay, IC50 = 0.17367 μM. |
SANGER |
SW1417 |
Growth inhibition assay |
|
|
Inhibition of human SW1417 cell growth in a cell viability assay, IC50 = 0.17327 μM. |
SANGER |
no-11 |
Growth inhibition assay |
|
|
Inhibition of human no-11 cell growth in a cell viability assay, IC50 = 0.16348 μM. |
SANGER |
MN-60 |
Growth inhibition assay |
|
|
Inhibition of human MN-60 cell growth in a cell viability assay, IC50 = 0.1676 μM. |
SANGER |
IST-MEL1 |
Growth inhibition assay |
|
|
Inhibition of human IST-MEL1 cell growth in a cell viability assay, IC50 = 0.15589 μM. |
SANGER |
SKG-IIIa |
Growth inhibition assay |
|
|
Inhibition of human SKG-IIIa cell growth in a cell viability assay, IC50 = 0.15554 μM. |
SANGER |
SW756 |
Growth inhibition assay |
|
|
Inhibition of human SW756 cell growth in a cell viability assay, IC50 = 0.14838 μM. |
SANGER |
ES4 |
Growth inhibition assay |
|
|
Inhibition of human ES4 cell growth in a cell viability assay, IC50 = 0.14614 μM. |
SANGER |
MFE-280 |
Growth inhibition assay |
|
|
Inhibition of human MFE-280 cell growth in a cell viability assay, IC50 = 0.14433 μM. |
SANGER |
KMOE-2 |
Growth inhibition assay |
|
|
Inhibition of human KMOE-2 cell growth in a cell viability assay, IC50 = 0.13623 μM. |
SANGER |
HT-1197 |
Growth inhibition assay |
|
|
Inhibition of human HT-1197 cell growth in a cell viability assay, IC50 = 0.1324 μM. |
SANGER |
EGI-1 |
Growth inhibition assay |
|
|
Inhibition of human EGI-1 cell growth in a cell viability assay, IC50 = 0.12994 μM. |
SANGER |
GMS-10 |
Growth inhibition assay |
|
|
Inhibition of human GMS-10 cell growth in a cell viability assay, IC50 = 0.1289 μM. |
SANGER |
HT-3 |
Growth inhibition assay |
|
|
Inhibition of human HT-3 cell growth in a cell viability assay, IC50 = 0.12829 μM. |
SANGER |
CAL-54 |
Growth inhibition assay |
|
|
Inhibition of human CAL-54 cell growth in a cell viability assay, IC50 = 0.12613 μM. |
SANGER |
NB6 |
Growth inhibition assay |
|
|
Inhibition of human NB6 cell growth in a cell viability assay, IC50 = 0.12568 μM. |
SANGER |
THP-1 |
Growth inhibition assay |
|
|
Inhibition of human THP-1 cell growth in a cell viability assay, IC50 = 0.12495 μM. |
SANGER |
EC-GI-10 |
Growth inhibition assay |
|
|
Inhibition of human EC-GI-10 cell growth in a cell viability assay, IC50 = 0.12227 μM. |
SANGER |
U-118-MG |
Growth inhibition assay |
|
|
Inhibition of human U-118-MG cell growth in a cell viability assay, IC50 = 0.12052 μM. |
SANGER |
COR-L279 |
Growth inhibition assay |
|
|
Inhibition of human COR-L279 cell growth in a cell viability assay, IC50 = 0.11861 μM. |
SANGER |
HCC1937 |
Growth inhibition assay |
|
|
Inhibition of human HCC1937 cell growth in a cell viability assay, IC50 = 0.11742 μM. |
SANGER |
TK10 |
Growth inhibition assay |
|
|
Inhibition of human TK10 cell growth in a cell viability assay, IC50 = 0.11625 μM. |
SANGER |
DOK |
Growth inhibition assay |
|
|
Inhibition of human DOK cell growth in a cell viability assay, IC50 = 0.11581 μM. |
SANGER |
NB10 |
Growth inhibition assay |
|
|
Inhibition of human NB10 cell growth in a cell viability assay, IC50 = 0.11454 μM. |
SANGER |
SNU-475 |
Growth inhibition assay |
|
|
Inhibition of human SNU-475 cell growth in a cell viability assay, IC50 = 0.11425 μM. |
SANGER |
SIMA |
Growth inhibition assay |
|
|
Inhibition of human SIMA cell growth in a cell viability assay, IC50 = 0.11296 μM. |
SANGER |
TYK-nu |
Growth inhibition assay |
|
|
Inhibition of human TYK-nu cell growth in a cell viability assay, IC50 = 0.11109 μM. |
SANGER |
OVCAR-5 |
Growth inhibition assay |
|
|
Inhibition of human OVCAR-5 cell growth in a cell viability assay, IC50 = 0.11016 μM. |
SANGER |
NCI-H2171 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2171 cell growth in a cell viability assay, IC50 = 0.10928 μM. |
SANGER |
WM-115 |
Growth inhibition assay |
|
|
Inhibition of human WM-115 cell growth in a cell viability assay, IC50 = 0.10834 μM. |
SANGER |
HL-60 |
Growth inhibition assay |
|
|
Inhibition of human HL-60 cell growth in a cell viability assay, IC50 = 0.10636 μM. |
SANGER |
L-428 |
Growth inhibition assay |
|
|
Inhibition of human L-428 cell growth in a cell viability assay, IC50 = 0.10562 μM. |
SANGER |
KG-1 |
Growth inhibition assay |
|
|
Inhibition of human KG-1 cell growth in a cell viability assay, IC50 = 0.10505 μM. |
SANGER |
PC-3 |
Growth inhibition assay |
|
|
Inhibition of human PC-3 cell growth in a cell viability assay, IC50 = 0.10448 μM. |
SANGER |
GAK |
Growth inhibition assay |
|
|
Inhibition of human GAK cell growth in a cell viability assay, IC50 = 0.10272 μM. |
SANGER |
C2BBe1 |
Growth inhibition assay |
|
|
Inhibition of human C2BBe1 cell growth in a cell viability assay, IC50 = 0.10183 μM. |
SANGER |
PLC-PRF-5 |
Growth inhibition assay |
|
|
Inhibition of human PLC-PRF-5 cell growth in a cell viability assay, IC50 = 0.1017 μM. |
SANGER |
MDA-MB-157 |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-157 cell growth in a cell viability assay, IC50 = 0.09878 μM. |
SANGER |
SNU-C1 |
Growth inhibition assay |
|
|
Inhibition of human SNU-C1 cell growth in a cell viability assay, IC50 = 0.09797 μM. |
SANGER |
J82 |
Growth inhibition assay |
|
|
Inhibition of human J82 cell growth in a cell viability assay, IC50 = 0.09779 μM. |
SANGER |
CHP-126 |
Growth inhibition assay |
|
|
Inhibition of human CHP-126 cell growth in a cell viability assay, IC50 = 0.09679 μM. |
SANGER |
NCI-H1792 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1792 cell growth in a cell viability assay, IC50 = 0.09513 μM. |
SANGER |
JAR |
Growth inhibition assay |
|
|
Inhibition of human JAR cell growth in a cell viability assay, IC50 = 0.0942 μM. |
SANGER |
RMG-I |
Growth inhibition assay |
|
|
Inhibition of human RMG-I cell growth in a cell viability assay, IC50 = 0.09379 μM. |
SANGER |
EHEB |
Growth inhibition assay |
|
|
Inhibition of human EHEB cell growth in a cell viability assay, IC50 = 0.09037 μM. |
SANGER |
TE-6 |
Growth inhibition assay |
|
|
Inhibition of human TE-6 cell growth in a cell viability assay, IC50 = 0.0872 μM. |
SANGER |
LB1047-RCC |
Growth inhibition assay |
|
|
Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50 = 0.08558 μM. |
SANGER |
Daudi |
Growth inhibition assay |
|
|
Inhibition of human Daudi cell growth in a cell viability assay, IC50 = 0.08492 μM. |
SANGER |
D-542MG |
Growth inhibition assay |
|
|
Inhibition of human D-542MG cell growth in a cell viability assay, IC50 = 0.08331 μM. |
SANGER |
D-502MG |
Growth inhibition assay |
|
|
Inhibition of human D-502MG cell growth in a cell viability assay, IC50 = 0.08263 μM. |
SANGER |
DG-75 |
Growth inhibition assay |
|
|
Inhibition of human DG-75 cell growth in a cell viability assay, IC50 = 0.08204 μM. |
SANGER |
Raji |
Growth inhibition assay |
|
|
Inhibition of human Raji cell growth in a cell viability assay, IC50 = 0.08164 μM. |
SANGER |
MS-1 |
Growth inhibition assay |
|
|
Inhibition of human MS-1 cell growth in a cell viability assay, IC50 = 0.07996 μM. |
SANGER |
SW1088 |
Growth inhibition assay |
|
|
Inhibition of human SW1088 cell growth in a cell viability assay, IC50 = 0.07944 μM. |
SANGER |
TGW |
Growth inhibition assay |
|
|
Inhibition of human TGW cell growth in a cell viability assay, IC50 = 0.0789 μM. |
SANGER |
NCI-H28 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H28 cell growth in a cell viability assay, IC50 = 0.07875 μM. |
SANGER |
UMC-11 |
Growth inhibition assay |
|
|
Inhibition of human UMC-11 cell growth in a cell viability assay, IC50 = 0.07701 μM. |
SANGER |
NB5 |
Growth inhibition assay |
|
|
Inhibition of human NB5 cell growth in a cell viability assay, IC50 = 0.07534 μM. |
SANGER |
KOSC-2 |
Growth inhibition assay |
|
|
Inhibition of human KOSC-2 cell growth in a cell viability assay, IC50 = 0.07457 μM. |
SANGER |
SW1990 |
Growth inhibition assay |
|
|
Inhibition of human SW1990 cell growth in a cell viability assay, IC50 = 0.07319 μM. |
SANGER |
KINGS-1 |
Growth inhibition assay |
|
|
Inhibition of human KINGS-1 cell growth in a cell viability assay, IC50 = 0.07265 μM. |
SANGER |
Caov-3 |
Growth inhibition assay |
|
|
Inhibition of human Caov-3 cell growth in a cell viability assay, IC50 = 0.0716 μM. |
SANGER |
GOTO |
Growth inhibition assay |
|
|
Inhibition of human GOTO cell growth in a cell viability assay, IC50 = 0.07054 μM. |
SANGER |
NCI-H524 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H524 cell growth in a cell viability assay, IC50 = 0.06987 μM. |
SANGER |
TGBC1TKB |
Growth inhibition assay |
|
|
Inhibition of human TGBC1TKB cell growth in a cell viability assay, IC50 = 0.0695 μM. |
SANGER |
LOXIMVI |
Growth inhibition assay |
|
|
Inhibition of human LOXIMVI cell growth in a cell viability assay, IC50 = 0.06903 μM. |
SANGER |
KARPAS-299 |
Growth inhibition assay |
|
|
Inhibition of human KARPAS-299 cell growth in a cell viability assay, IC50 = 0.0675 μM. |
SANGER |
NCI-H747 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50 = 0.06719 μM. |
SANGER |
D-392MG |
Growth inhibition assay |
|
|
Inhibition of human D-392MG cell growth in a cell viability assay, IC50 = 0.06593 μM. |
SANGER |
D-336MG |
Growth inhibition assay |
|
|
Inhibition of human D-336MG cell growth in a cell viability assay, IC50 = 0.06389 μM. |
SANGER |
BB65-RCC |
Growth inhibition assay |
|
|
Inhibition of human BB65-RCC cell growth in a cell viability assay, IC50 = 0.06184 μM. |
SANGER |
NCI-H2052 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2052 cell growth in a cell viability assay, IC50 = 0.06098 μM. |
SANGER |
NCI-H1651 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1651 cell growth in a cell viability assay, IC50 = 0.06064 μM. |
SANGER |
KMS-12-PE |
Growth inhibition assay |
|
|
Inhibition of human KMS-12-PE cell growth in a cell viability assay, IC50 = 0.06015 μM. |
SANGER |
NCI-H23 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H23 cell growth in a cell viability assay, IC50 = 0.06005 μM. |
SANGER |
NCI-H82 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H82 cell growth in a cell viability assay, IC50 = 0.06002 μM. |
SANGER |
CaR-1 |
Growth inhibition assay |
|
|
Inhibition of human CaR-1 cell growth in a cell viability assay, IC50 = 0.05907 μM. |
SANGER |
BEN |
Growth inhibition assay |
|
|
Inhibition of human BEN cell growth in a cell viability assay, IC50 = 0.05811 μM. |
SANGER |
NCI-H1092 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1092 cell growth in a cell viability assay, IC50 = 0.05807 μM. |
SANGER |
GCIY |
Growth inhibition assay |
|
|
Inhibition of human GCIY cell growth in a cell viability assay, IC50 = 0.05788 μM. |
SANGER |
HCC2218 |
Growth inhibition assay |
|
|
Inhibition of human HCC2218 cell growth in a cell viability assay, IC50 = 0.05706 μM. |
SANGER |
NCI-H748 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H748 cell growth in a cell viability assay, IC50 = 0.05695 μM. |
SANGER |
T84 |
Growth inhibition assay |
|
|
Inhibition of human T84 cell growth in a cell viability assay, IC50 = 0.05386 μM. |
SANGER |
NCI-H1395 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1395 cell growth in a cell viability assay, IC50 = 0.05349 μM. |
SANGER |
COLO-680N |
Growth inhibition assay |
|
|
Inhibition of human COLO-680N cell growth in a cell viability assay, IC50 = 0.05331 μM. |
SANGER |
LU-139 |
Growth inhibition assay |
|
|
Inhibition of human LU-139 cell growth in a cell viability assay, IC50 = 0.05288 μM. |
SANGER |
SK-LU-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-LU-1 cell growth in a cell viability assay, IC50 = 0.05183 μM. |
SANGER |
HOP-92 |
Growth inhibition assay |
|
|
Inhibition of human HOP-92 cell growth in a cell viability assay, IC50 = 0.0513 μM. |
SANGER |
NCI-H209 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H209 cell growth in a cell viability assay, IC50 = 0.0508 μM. |
SANGER |
GCT |
Growth inhibition assay |
|
|
Inhibition of human GCT cell growth in a cell viability assay, IC50 = 0.05077 μM. |
SANGER |
NCI-H2405 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2405 cell growth in a cell viability assay, IC50 = 0.05071 μM. |
SANGER |
FADU |
Growth inhibition assay |
|
|
Inhibition of human FADU cell growth in a cell viability assay, IC50 = 0.04852 μM. |
SANGER |
DU-4475 |
Growth inhibition assay |
|
|
Inhibition of human DU-4475 cell growth in a cell viability assay, IC50 = 0.04813 μM. |
SANGER |
COLO-824 |
Growth inhibition assay |
|
|
Inhibition of human COLO-824 cell growth in a cell viability assay, IC50 = 0.04724 μM. |
SANGER |
LU-134-A |
Growth inhibition assay |
|
|
Inhibition of human LU-134-A cell growth in a cell viability assay, IC50 = 0.04722 μM. |
SANGER |
PANC-08-13 |
Growth inhibition assay |
|
|
Inhibition of human PANC-08-13 cell growth in a cell viability assay, IC50 = 0.04695 μM. |
SANGER |
LB373-MEL-D |
Growth inhibition assay |
|
|
Inhibition of human LB373-MEL-D cell growth in a cell viability assay, IC50 = 0.0468 μM. |
SANGER |
TE-8 |
Growth inhibition assay |
|
|
Inhibition of human TE-8 cell growth in a cell viability assay, IC50 = 0.04598 μM. |
SANGER |
NCI-SNU-5 |
Growth inhibition assay |
|
|
Inhibition of human NCI-SNU-5 cell growth in a cell viability assay, IC50 = 0.04585 μM. |
SANGER |
ACHN |
Growth inhibition assay |
|
|
Inhibition of human ACHN cell growth in a cell viability assay, IC50 = 0.04577 μM. |
SANGER |
LAMA-84 |
Growth inhibition assay |
|
|
Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50 = 0.04575 μM. |
SANGER |
no-10 |
Growth inhibition assay |
|
|
Inhibition of human no-10 cell growth in a cell viability assay, IC50 = 0.04561 μM. |
SANGER |
CAMA-1 |
Growth inhibition assay |
|
|
Inhibition of human CAMA-1 cell growth in a cell viability assay, IC50 = 0.04557 μM. |
SANGER |
NB69 |
Growth inhibition assay |
|
|
Inhibition of human NB69 cell growth in a cell viability assay, IC50 = 0.04553 μM. |
SANGER |
NCI-H630 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H630 cell growth in a cell viability assay, IC50 = 0.04551 μM. |
SANGER |
CP66-MEL |
Growth inhibition assay |
|
|
Inhibition of human CP66-MEL cell growth in a cell viability assay, IC50 = 0.04508 μM. |
SANGER |
NCI-H345 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H345 cell growth in a cell viability assay, IC50 = 0.04488 μM. |
SANGER |
EM-2 |
Growth inhibition assay |
|
|
Inhibition of human EM-2 cell growth in a cell viability assay, IC50 = 0.0448 μM. |
SANGER |
LC-1F |
Growth inhibition assay |
|
|
Inhibition of human LC-1F cell growth in a cell viability assay, IC50 = 0.04479 μM. |
SANGER |
NCI-H1694 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1694 cell growth in a cell viability assay, IC50 = 0.04439 μM. |
SANGER |
NCI-N87 |
Growth inhibition assay |
|
|
Inhibition of human NCI-N87 cell growth in a cell viability assay, IC50 = 0.04409 μM. |
SANGER |
CAL-120 |
Growth inhibition assay |
|
|
Inhibition of human CAL-120 cell growth in a cell viability assay, IC50 = 0.04357 μM. |
SANGER |
CP50-MEL-B |
Growth inhibition assay |
|
|
Inhibition of human CP50-MEL-B cell growth in a cell viability assay, IC50 = 0.04344 μM. |
SANGER |
MZ2-MEL |
Growth inhibition assay |
|
|
Inhibition of human MZ2-MEL cell growth in a cell viability assay, IC50 = 0.04295 μM. |
SANGER |
EW-11 |
Growth inhibition assay |
|
|
Inhibition of human EW-11 cell growth in a cell viability assay, IC50 = 0.04268 μM. |
SANGER |
OAW-42 |
Growth inhibition assay |
|
|
Inhibition of human OAW-42 cell growth in a cell viability assay, IC50 = 0.04245 μM. |
SANGER |
ES6 |
Growth inhibition assay |
|
|
Inhibition of human ES6 cell growth in a cell viability assay, IC50 = 0.0424 μM. |
SANGER |
K5 |
Growth inhibition assay |
|
|
Inhibition of human K5 cell growth in a cell viability assay, IC50 = 0.04189 μM. |
SANGER |
NOS-1 |
Growth inhibition assay |
|
|
Inhibition of human NOS-1 cell growth in a cell viability assay, IC50 = 0.04133 μM. |
SANGER |
NCI-H1650 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50 = 0.04068 μM. |
SANGER |
NCI-H889 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H889 cell growth in a cell viability assay, IC50 = 0.04027 μM. |
SANGER |
CAS-1 |
Growth inhibition assay |
|
|
Inhibition of human CAS-1 cell growth in a cell viability assay, IC50 = 0.04006 μM. |
SANGER |
IST-SL1 |
Growth inhibition assay |
|
|
Inhibition of human IST-SL1 cell growth in a cell viability assay, IC50 = 0.03932 μM. |
SANGER |
NCI-H2141 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2141 cell growth in a cell viability assay, IC50 = 0.03899 μM. |
SANGER |
NCI-SNU-16 |
Growth inhibition assay |
|
|
Inhibition of human NCI-SNU-16 cell growth in a cell viability assay, IC50 = 0.03856 μM. |
SANGER |
HEL |
Growth inhibition assay |
|
|
Inhibition of human HEL cell growth in a cell viability assay, IC50 = 0.03828 μM. |
SANGER |
A375 |
Growth inhibition assay |
|
|
Inhibition of human A375 cell growth in a cell viability assay, IC50 = 0.03821 μM. |
SANGER |
SW626 |
Growth inhibition assay |
|
|
Inhibition of human SW626 cell growth in a cell viability assay, IC50 = 0.03767 μM. |
SANGER |
MDA-MB-231 |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-231 cell growth in a cell viability assay, IC50 = 0.03739 μM. |
SANGER |
HuP-T4 |
Growth inhibition assay |
|
|
Inhibition of human HuP-T4 cell growth in a cell viability assay, IC50 = 0.0373 μM. |
SANGER |
NCI-H1581 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50 = 0.03716 μM. |
SANGER |
MLMA |
Growth inhibition assay |
|
|
Inhibition of human MLMA cell growth in a cell viability assay, IC50 = 0.0369 μM. |
SANGER |
IPC-298 |
Growth inhibition assay |
|
|
Inhibition of human IPC-298 cell growth in a cell viability assay, IC50 = 0.03656 μM. |
SANGER |
NCI-H1882 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1882 cell growth in a cell viability assay, IC50 = 0.03654 μM. |
SANGER |
COLO-741 |
Growth inhibition assay |
|
|
Inhibition of human COLO-741 cell growth in a cell viability assay, IC50 = 0.03569 μM. |
SANGER |
NCI-H1304 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1304 cell growth in a cell viability assay, IC50 = 0.03516 μM. |
SANGER |
TE-441-T |
Growth inhibition assay |
|
|
Inhibition of human TE-441-T cell growth in a cell viability assay, IC50 = 0.03486 μM. |
SANGER |
COR-L88 |
Growth inhibition assay |
|
|
Inhibition of human COR-L88 cell growth in a cell viability assay, IC50 = 0.03482 μM. |
SANGER |
DV-90 |
Growth inhibition assay |
|
|
Inhibition of human DV-90 cell growth in a cell viability assay, IC50 = 0.03448 μM. |
SANGER |
OS-RC-2 |
Growth inhibition assay |
|
|
Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50 = 0.03434 μM. |
SANGER |
SW1573 |
Growth inhibition assay |
|
|
Inhibition of human SW1573 cell growth in a cell viability assay, IC50 = 0.034 μM. |
SANGER |
WSU-NHL |
Growth inhibition assay |
|
|
Inhibition of human WSU-NHL cell growth in a cell viability assay, IC50 = 0.03365 μM. |
SANGER |
NCI-H2081 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2081 cell growth in a cell viability assay, IC50 = 0.03362 μM. |
SANGER |
AM-38 |
Growth inhibition assay |
|
|
Inhibition of human AM-38 cell growth in a cell viability assay, IC50 = 0.03355 μM. |
SANGER |
UACC-62 |
Growth inhibition assay |
|
|
Inhibition of human UACC-62 cell growth in a cell viability assay, IC50 = 0.03345 μM. |
SANGER |
SN12C |
Growth inhibition assay |
|
|
Inhibition of human SN12C cell growth in a cell viability assay, IC50 = 0.03312 μM. |
SANGER |
NCI-H441 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H441 cell growth in a cell viability assay, IC50 = 0.03312 μM. |
SANGER |
NCI-SNU-1 |
Growth inhibition assay |
|
|
Inhibition of human NCI-SNU-1 cell growth in a cell viability assay, IC50 = 0.03275 μM. |
SANGER |
G-402 |
Growth inhibition assay |
|
|
Inhibition of human G-402 cell growth in a cell viability assay, IC50 = 0.03208 μM. |
SANGER |
CAL-27 |
Growth inhibition assay |
|
|
Inhibition of human CAL-27 cell growth in a cell viability assay, IC50 = 0.03204 μM. |
SANGER |
HT-1376 |
Growth inhibition assay |
|
|
Inhibition of human HT-1376 cell growth in a cell viability assay, IC50 = 0.03146 μM. |
SANGER |
BC-3 |
Growth inhibition assay |
|
|
Inhibition of human BC-3 cell growth in a cell viability assay, IC50 = 0.03112 μM. |
SANGER |
COR-L105 |
Growth inhibition assay |
|
|
Inhibition of human COR-L105 cell growth in a cell viability assay, IC50 = 0.03094 μM. |
SANGER |
HCC70 |
Growth inhibition assay |
|
|
Inhibition of human HCC70 cell growth in a cell viability assay, IC50 = 0.03057 μM. |
SANGER |
Capan-2 |
Growth inhibition assay |
|
|
Inhibition of human Capan-2 cell growth in a cell viability assay, IC50 = 0.03045 μM. |
SANGER |
UACC-257 |
Growth inhibition assay |
|
|
Inhibition of human UACC-257 cell growth in a cell viability assay, IC50 = 0.03044 μM. |
SANGER |
BV-173 |
Growth inhibition assay |
|
|
Inhibition of human BV-173 cell growth in a cell viability assay, IC50 = 0.03041 μM. |
SANGER |
NCI-H1963 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1963 cell growth in a cell viability assay, IC50 = 0.03032 μM. |
SANGER |
L-540 |
Growth inhibition assay |
|
|
Inhibition of human L-540 cell growth in a cell viability assay, IC50 = 0.03002 μM. |
SANGER |
HuH-7 |
Growth inhibition assay |
|
|
Inhibition of human HuH-7 cell growth in a cell viability assay, IC50 = 0.02957 μM. |
SANGER |
NCI-H2126 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50 = 0.02932 μM. |
SANGER |
SJRH30 |
Growth inhibition assay |
|
|
Inhibition of human SJRH30 cell growth in a cell viability assay, IC50 = 0.02931 μM. |
SANGER |
HD-MY-Z |
Growth inhibition assay |
|
|
Inhibition of human HD-MY-Z cell growth in a cell viability assay, IC50 = 0.02924 μM. |
SANGER |
LB831-BLC |
Growth inhibition assay |
|
|
Inhibition of human LB831-BLC cell growth in a cell viability assay, IC50 = 0.02915 μM. |
SANGER |
COLO-668 |
Growth inhibition assay |
|
|
Inhibition of human COLO-668 cell growth in a cell viability assay, IC50 = 0.0285 μM. |
SANGER |
NCI-H1623 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1623 cell growth in a cell viability assay, IC50 = 0.02849 μM. |
SANGER |
BT-474 |
Growth inhibition assay |
|
|
Inhibition of human BT-474 cell growth in a cell viability assay, IC50 = 0.02848 μM. |
SANGER |
ES3 |
Growth inhibition assay |
|
|
Inhibition of human ES3 cell growth in a cell viability assay, IC50 = 0.02815 μM. |
SANGER |
SW962 |
Growth inhibition assay |
|
|
Inhibition of human SW962 cell growth in a cell viability assay, IC50 = 0.02783 μM. |
SANGER |
U-87-MG |
Growth inhibition assay |
|
|
Inhibition of human U-87-MG cell growth in a cell viability assay, IC50 = 0.02709 μM. |
SANGER |
TCCSUP |
Growth inhibition assay |
|
|
Inhibition of human TCCSUP cell growth in a cell viability assay, IC50 = 0.02706 μM. |
SANGER |
NH-12 |
Growth inhibition assay |
|
|
Inhibition of human NH-12 cell growth in a cell viability assay, IC50 = 0.02702 μM. |
SANGER |
HTC-C3 |
Growth inhibition assay |
|
|
Inhibition of human HTC-C3 cell growth in a cell viability assay, IC50 = 0.02649 μM. |
SANGER |
A498 |
Growth inhibition assay |
|
|
Inhibition of human A498 cell growth in a cell viability assay, IC50 = 0.02621 μM. |
SANGER |
NCI-H2347 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2347 cell growth in a cell viability assay, IC50 = 0.02611 μM. |
SANGER |
NB1 |
Growth inhibition assay |
|
|
Inhibition of human NB1 cell growth in a cell viability assay, IC50 = 0.02608 μM. |
SANGER |
P12-ICHIKAWA |
Growth inhibition assay |
|
|
Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50 = 0.02515 μM. |
SANGER |
NCI-H226 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H226 cell growth in a cell viability assay, IC50 = 0.02495 μM. |
SANGER |
GDM-1 |
Growth inhibition assay |
|
|
Inhibition of human GDM-1 cell growth in a cell viability assay, IC50 = 0.02461 μM. |
SANGER |
CHP-212 |
Growth inhibition assay |
|
|
Inhibition of human CHP-212 cell growth in a cell viability assay, IC50 = 0.02459 μM. |
SANGER |
LU-65 |
Growth inhibition assay |
|
|
Inhibition of human LU-65 cell growth in a cell viability assay, IC50 = 0.02449 μM. |
SANGER |
SW684 |
Growth inhibition assay |
|
|
Inhibition of human SW684 cell growth in a cell viability assay, IC50 = 0.02416 μM. |
SANGER |
MDA-MB-415 |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-415 cell growth in a cell viability assay, IC50 = 0.0241 μM. |
SANGER |
NCI-H1417 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1417 cell growth in a cell viability assay, IC50 = 0.02406 μM. |
SANGER |
HCC1806 |
Growth inhibition assay |
|
|
Inhibition of human HCC1806 cell growth in a cell viability assay, IC50 = 0.02389 μM. |
SANGER |
KYSE-140 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-140 cell growth in a cell viability assay, IC50 = 0.02384 μM. |
SANGER |
KARPAS-422 |
Growth inhibition assay |
|
|
Inhibition of human KARPAS-422 cell growth in a cell viability assay, IC50 = 0.02329 μM. |
SANGER |
C-4-II |
Growth inhibition assay |
|
|
Inhibition of human C-4-II cell growth in a cell viability assay, IC50 = 0.02301 μM. |
SANGER |
HEC-1 |
Growth inhibition assay |
|
|
Inhibition of human HEC-1 cell growth in a cell viability assay, IC50 = 0.02272 μM. |
SANGER |
CA46 |
Growth inhibition assay |
|
|
Inhibition of human CA46 cell growth in a cell viability assay, IC50 = 0.02217 μM. |
SANGER |
KP-N-YS |
Growth inhibition assay |
|
|
Inhibition of human KP-N-YS cell growth in a cell viability assay, IC50 = 0.02183 μM. |
SANGER |
EFO-21 |
Growth inhibition assay |
|
|
Inhibition of human EFO-21 cell growth in a cell viability assay, IC50 = 0.02171 μM. |
SANGER |
HT |
Growth inhibition assay |
|
|
Inhibition of human HT cell growth in a cell viability assay, IC50 = 0.02158 μM. |
SANGER |
A3-KAW |
Growth inhibition assay |
|
|
Inhibition of human A3-KAW cell growth in a cell viability assay, IC50 = 0.02157 μM. |
SANGER |
UM-UC-3 |
Growth inhibition assay |
|
|
Inhibition of human UM-UC-3 cell growth in a cell viability assay, IC50 = 0.02122 μM. |
SANGER |
K052 |
Growth inhibition assay |
|
|
Inhibition of human K052 cell growth in a cell viability assay, IC50 = 0.02119 μM. |
SANGER |
M14 |
Growth inhibition assay |
|
|
Inhibition of human M14 cell growth in a cell viability assay, IC50 = 0.02112 μM. |
SANGER |
ME-180 |
Growth inhibition assay |
|
|
Inhibition of human ME-180 cell growth in a cell viability assay, IC50 = 0.02104 μM. |
SANGER |
647-V |
Growth inhibition assay |
|
|
Inhibition of human 647-V cell growth in a cell viability assay, IC50 = 0.02089 μM. |
SANGER |
HCE-4 |
Growth inhibition assay |
|
|
Inhibition of human HCE-4 cell growth in a cell viability assay, IC50 = 0.02085 μM. |
SANGER |
MEG-01 |
Growth inhibition assay |
|
|
Inhibition of human MEG-01 cell growth in a cell viability assay, IC50 = 0.0208 μM. |
SANGER |
CAL-12T |
Growth inhibition assay |
|
|
Inhibition of human CAL-12T cell growth in a cell viability assay, IC50 = 0.02076 μM. |
SANGER |
MONO-MAC-6 |
Growth inhibition assay |
|
|
Inhibition of human MONO-MAC-6 cell growth in a cell viability assay, IC50 = 0.02061 μM. |
SANGER |
PFSK-1 |
Growth inhibition assay |
|
|
Inhibition of human PFSK-1 cell growth in a cell viability assay, IC50 = 0.02054 μM. |
SANGER |
MMAC-SF |
Growth inhibition assay |
|
|
Inhibition of human MMAC-SF cell growth in a cell viability assay, IC50 = 0.02046 μM. |
SANGER |
OE33 |
Growth inhibition assay |
|
|
Inhibition of human OE33 cell growth in a cell viability assay, IC50 = 0.02043 μM. |
SANGER |
NCI-H661 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H661 cell growth in a cell viability assay, IC50 = 0.02035 μM. |
SANGER |
TGBC24TKB |
Growth inhibition assay |
|
|
Inhibition of human TGBC24TKB cell growth in a cell viability assay, IC50 = 0.02014 μM. |
SANGER |
SW948 |
Growth inhibition assay |
|
|
Inhibition of human SW948 cell growth in a cell viability assay, IC50 = 0.01985 μM. |
SANGER |
CTB-1 |
Growth inhibition assay |
|
|
Inhibition of human CTB-1 cell growth in a cell viability assay, IC50 = 0.0198 μM. |
SANGER |
DB |
Growth inhibition assay |
|
|
Inhibition of human DB cell growth in a cell viability assay, IC50 = 0.01941 μM. |
SANGER |
NCI-H1793 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1793 cell growth in a cell viability assay, IC50 = 0.01924 μM. |
SANGER |
Ca-Ski |
Growth inhibition assay |
|
|
Inhibition of human Ca-Ski cell growth in a cell viability assay, IC50 = 0.01912 μM. |
SANGER |
VM-CUB-1 |
Growth inhibition assay |
|
|
Inhibition of human VM-CUB-1 cell growth in a cell viability assay, IC50 = 0.01907 μM. |
SANGER |
NOMO-1 |
Growth inhibition assay |
|
|
Inhibition of human NOMO-1 cell growth in a cell viability assay, IC50 = 0.01902 μM. |
SANGER |
T98G |
Growth inhibition assay |
|
|
Inhibition of human T98G cell growth in a cell viability assay, IC50 = 0.01891 μM. |
SANGER |
VMRC-RCZ |
Growth inhibition assay |
|
|
Inhibition of human VMRC-RCZ cell growth in a cell viability assay, IC50 = 0.01882 μM. |
SANGER |
HCC2157 |
Growth inhibition assay |
|
|
Inhibition of human HCC2157 cell growth in a cell viability assay, IC50 = 0.0188 μM. |
SANGER |
Calu-3 |
Growth inhibition assay |
|
|
Inhibition of human Calu-3 cell growth in a cell viability assay, IC50 = 0.018 μM. |
SANGER |
LNCaP-Clone-FGC |
Growth inhibition assay |
|
|
Inhibition of human LNCaP-Clone-FGC cell growth in a cell viability assay, IC50 = 0.01793 μM. |
SANGER |
KYSE-520 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-520 cell growth in a cell viability assay, IC50 = 0.01783 μM. |
SANGER |
ARH-77 |
Growth inhibition assay |
|
|
Inhibition of human ARH-77 cell growth in a cell viability assay, IC50 = 0.01776 μM. |
SANGER |
MZ1-PC |
Growth inhibition assay |
|
|
Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50 = 0.0177 μM. |
SANGER |
KASUMI-1 |
Growth inhibition assay |
|
|
Inhibition of human KASUMI-1 cell growth in a cell viability assay, IC50 = 0.01769 μM. |
SANGER |
MHH-NB-11 |
Growth inhibition assay |
|
|
Inhibition of human MHH-NB-11 cell growth in a cell viability assay, IC50 = 0.01765 μM. |
SANGER |
C8166 |
Growth inhibition assay |
|
|
Inhibition of human C8166 cell growth in a cell viability assay, IC50 = 0.01756 μM. |
SANGER |
U-266 |
Growth inhibition assay |
|
|
Inhibition of human U-266 cell growth in a cell viability assay, IC50 = 0.01747 μM. |
SANGER |
NCI-H1755 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1755 cell growth in a cell viability assay, IC50 = 0.01736 μM. |
SANGER |
SK-MEL-3 |
Growth inhibition assay |
|
|
Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50 = 0.01733 μM. |
SANGER |
IST-SL2 |
Growth inhibition assay |
|
|
Inhibition of human IST-SL2 cell growth in a cell viability assay, IC50 = 0.01714 μM. |
SANGER |
RPMI-8226 |
Growth inhibition assay |
|
|
Inhibition of human RPMI-8226 cell growth in a cell viability assay, IC50 = 0.01703 μM. |
SANGER |
COLO-800 |
Growth inhibition assay |
|
|
Inhibition of human COLO-800 cell growth in a cell viability assay, IC50 = 0.01695 μM. |
SANGER |
769-P |
Growth inhibition assay |
|
|
Inhibition of human 769-P cell growth in a cell viability assay, IC50 = 0.01692 μM. |
SANGER |
EW-7 |
Growth inhibition assay |
|
|
Inhibition of human EW-7 cell growth in a cell viability assay, IC50 = 0.0167 μM. |
SANGER |
KYSE-70 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-70 cell growth in a cell viability assay, IC50 = 0.01669 μM. |
SANGER |
HPAF-II |
Growth inhibition assay |
|
|
Inhibition of human HPAF-II cell growth in a cell viability assay, IC50 = 0.01662 μM. |
SANGER |
SF268 |
Growth inhibition assay |
|
|
Inhibition of human SF268 cell growth in a cell viability assay, IC50 = 0.01631 μM. |
SANGER |
NCI-H650 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H650 cell growth in a cell viability assay, IC50 = 0.01608 μM. |
SANGER |
NCI-H838 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H838 cell growth in a cell viability assay, IC50 = 0.01604 μM. |
SANGER |
HDLM-2 |
Growth inhibition assay |
|
|
Inhibition of human HDLM-2 cell growth in a cell viability assay, IC50 = 0.0159 μM. |
SANGER |
HCC1395 |
Growth inhibition assay |
|
|
Inhibition of human HCC1395 cell growth in a cell viability assay, IC50 = 0.01587 μM. |
SANGER |
DJM-1 |
Growth inhibition assay |
|
|
Inhibition of human DJM-1 cell growth in a cell viability assay, IC50 = 0.01587 μM. |
SANGER |
MC116 |
Growth inhibition assay |
|
|
Inhibition of human MC116 cell growth in a cell viability assay, IC50 = 0.01554 μM. |
SANGER |
SH-4 |
Growth inhibition assay |
|
|
Inhibition of human SH-4 cell growth in a cell viability assay, IC50 = 0.01552 μM. |
SANGER |
NCI-H510A |
Growth inhibition assay |
|
|
Inhibition of human NCI-H510A cell growth in a cell viability assay, IC50 = 0.01545 μM. |
SANGER |
CAL-148 |
Growth inhibition assay |
|
|
Inhibition of human CAL-148 cell growth in a cell viability assay, IC50 = 0.0154 μM. |
SANGER |
OAW-28 |
Growth inhibition assay |
|
|
Inhibition of human OAW-28 cell growth in a cell viability assay, IC50 = 0.01522 μM. |
SANGER |
Mewo |
Growth inhibition assay |
|
|
Inhibition of human Mewo cell growth in a cell viability assay, IC50 = 0.01518 μM. |
SANGER |
NMC-G1 |
Growth inhibition assay |
|
|
Inhibition of human NMC-G1 cell growth in a cell viability assay, IC50 = 0.01495 μM. |
SANGER |
SW780 |
Growth inhibition assay |
|
|
Inhibition of human SW780 cell growth in a cell viability assay, IC50 = 0.01487 μM. |
SANGER |
NCI-H446 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H446 cell growth in a cell viability assay, IC50 = 0.01481 μM. |
SANGER |
CAPAN-1 |
Growth inhibition assay |
|
|
Inhibition of human CAPAN-1 cell growth in a cell viability assay, IC50 = 0.01418 μM. |
SANGER |
SF539 |
Growth inhibition assay |
|
|
Inhibition of human SF539 cell growth in a cell viability assay, IC50 = 0.0141 μM. |
SANGER |
NCI-H1734 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1734 cell growth in a cell viability assay, IC50 = 0.0141 μM. |
SANGER |
JEG-3 |
Growth inhibition assay |
|
|
Inhibition of human JEG-3 cell growth in a cell viability assay, IC50 = 0.01407 μM. |
SANGER |
M059J |
Growth inhibition assay |
|
|
Inhibition of human M059J cell growth in a cell viability assay, IC50 = 0.01406 μM. |
SANGER |
NCI-H187 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H187 cell growth in a cell viability assay, IC50 = 0.01402 μM. |
SANGER |
A172 |
Growth inhibition assay |
|
|
Inhibition of human A172 cell growth in a cell viability assay, IC50 = 0.01392 μM. |
SANGER |
NEC8 |
Growth inhibition assay |
|
|
Inhibition of human NEC8 cell growth in a cell viability assay, IC50 = 0.01391 μM. |
SANGER |
HCC1187 |
Growth inhibition assay |
|
|
Inhibition of human HCC1187 cell growth in a cell viability assay, IC50 = 0.01386 μM. |
SANGER |
CMK |
Growth inhibition assay |
|
|
Inhibition of human CMK cell growth in a cell viability assay, IC50 = 0.01372 μM. |
SANGER |
COLO-684 |
Growth inhibition assay |
|
|
Inhibition of human COLO-684 cell growth in a cell viability assay, IC50 = 0.01366 μM. |
SANGER |
NCI-H1299 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1299 cell growth in a cell viability assay, IC50 = 0.01363 μM. |
SANGER |
NCI-H1436 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1436 cell growth in a cell viability assay, IC50 = 0.01358 μM. |
SANGER |
OE19 |
Growth inhibition assay |
|
|
Inhibition of human OE19 cell growth in a cell viability assay, IC50 = 0.01324 μM. |
SANGER |
TE-1 |
Growth inhibition assay |
|
|
Inhibition of human TE-1 cell growth in a cell viability assay, IC50 = 0.01306 μM. |
SANGER |
GAMG |
Growth inhibition assay |
|
|
Inhibition of human GAMG cell growth in a cell viability assay, IC50 = 0.01303 μM. |
SANGER |
HuO-3N1 |
Growth inhibition assay |
|
|
Inhibition of human HuO-3N1 cell growth in a cell viability assay, IC50 = 0.01298 μM. |
SANGER |
NCI-H2228 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50 = 0.01292 μM. |
SANGER |
NCI-H1563 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1563 cell growth in a cell viability assay, IC50 = 0.01281 μM. |
SANGER |
MOLT-16 |
Growth inhibition assay |
|
|
Inhibition of human MOLT-16 cell growth in a cell viability assay, IC50 = 0.01278 μM. |
SANGER |
SJSA-1 |
Growth inhibition assay |
|
|
Inhibition of human SJSA-1 cell growth in a cell viability assay, IC50 = 0.01261 μM. |
SANGER |
D-247MG |
Growth inhibition assay |
|
|
Inhibition of human D-247MG cell growth in a cell viability assay, IC50 = 0.0126 μM. |
SANGER |
LK-2 |
Growth inhibition assay |
|
|
Inhibition of human LK-2 cell growth in a cell viability assay, IC50 = 0.01251 μM. |
SANGER |
SCC-25 |
Growth inhibition assay |
|
|
Inhibition of human SCC-25 cell growth in a cell viability assay, IC50 = 0.01248 μM. |
SANGER |
SK-PN-DW |
Growth inhibition assay |
|
|
Inhibition of human SK-PN-DW cell growth in a cell viability assay, IC50 = 0.01247 μM. |
SANGER |
SNB75 |
Growth inhibition assay |
|
|
Inhibition of human SNB75 cell growth in a cell viability assay, IC50 = 0.01245 μM. |
SANGER |
SK-MEL-30 |
Growth inhibition assay |
|
|
Inhibition of human SK-MEL-30 cell growth in a cell viability assay, IC50 = 0.01241 μM. |
SANGER |
L-363 |
Growth inhibition assay |
|
|
Inhibition of human L-363 cell growth in a cell viability assay, IC50 = 0.01238 μM. |
SANGER |
BE-13 |
Growth inhibition assay |
|
|
Inhibition of human BE-13 cell growth in a cell viability assay, IC50 = 0.01237 μM. |
SANGER |
BT-20 |
Growth inhibition assay |
|
|
Inhibition of human BT-20 cell growth in a cell viability assay, IC50 = 0.01236 μM. |
SANGER |
RPMI-8402 |
Growth inhibition assay |
|
|
Inhibition of human RPMI-8402 cell growth in a cell viability assay, IC50 = 0.0123 μM. |
SANGER |
U-698-M |
Growth inhibition assay |
|
|
Inhibition of human U-698-M cell growth in a cell viability assay, IC50 = 0.01217 μM. |
SANGER |
SF295 |
Growth inhibition assay |
|
|
Inhibition of human SF295 cell growth in a cell viability assay, IC50 = 0.01203 μM. |
SANGER |
MKN1 |
Growth inhibition assay |
|
|
Inhibition of human MKN1 cell growth in a cell viability assay, IC50 = 0.01177 μM. |
SANGER |
PF-382 |
Growth inhibition assay |
|
|
Inhibition of human PF-382 cell growth in a cell viability assay, IC50 = 0.01172 μM. |
SANGER |
TE-5 |
Growth inhibition assay |
|
|
Inhibition of human TE-5 cell growth in a cell viability assay, IC50 = 0.01169 μM. |
SANGER |
NCI-H2170 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2170 cell growth in a cell viability assay, IC50 = 0.0116 μM. |
SANGER |
IMR-5 |
Growth inhibition assay |
|
|
Inhibition of human IMR-5 cell growth in a cell viability assay, IC50 = 0.01125 μM. |
SANGER |
RH-1 |
Growth inhibition assay |
|
|
Inhibition of human RH-1 cell growth in a cell viability assay, IC50 = 0.01102 μM. |
SANGER |
BFTC-909 |
Growth inhibition assay |
|
|
Inhibition of human BFTC-909 cell growth in a cell viability assay, IC50 = 0.01078 μM. |
SANGER |
JiyoyeP-2003 |
Growth inhibition assay |
|
|
Inhibition of human JiyoyeP-2003 cell growth in a cell viability assay, IC50 = 0.01073 μM. |
SANGER |
HCC1599 |
Growth inhibition assay |
|
|
Inhibition of human HCC1599 cell growth in a cell viability assay, IC50 = 0.01057 μM. |
SANGER |
MV-4-11 |
Growth inhibition assay |
|
|
Inhibition of human MV-4-11 cell growth in a cell viability assay, IC50 = 0.01039 μM. |
SANGER |
Ca9-22 |
Growth inhibition assay |
|
|
Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50 = 0.01027 μM. |
SANGER |
OCI-AML2 |
Growth inhibition assay |
|
|
Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50 = 0.01025 μM. |
SANGER |
MZ7-mel |
Growth inhibition assay |
|
|
Inhibition of human MZ7-mel cell growth in a cell viability assay, IC50 = 0.01024 μM. |
SANGER |
SNU-387 |
Growth inhibition assay |
|
|
Inhibition of human SNU-387 cell growth in a cell viability assay, IC50 = 0.01023 μM. |
SANGER |
HLE |
Growth inhibition assay |
|
|
Inhibition of human HLE cell growth in a cell viability assay, IC50 = 0.01021 μM. |
SANGER |
RERF-LC-MS |
Growth inhibition assay |
|
|
Inhibition of human RERF-LC-MS cell growth in a cell viability assay, IC50 = 0.01018 μM. |
SANGER |
P30-OHK |
Growth inhibition assay |
|
|
Inhibition of human P30-OHK cell growth in a cell viability assay, IC50 = 0.0101 μM. |
SANGER |
HCC1954 |
Growth inhibition assay |
|
|
Inhibition of human HCC1954 cell growth in a cell viability assay, IC50 = 0.01009 μM. |
SANGER |
RPMI-2650 |
Growth inhibition assay |
|
|
Inhibition of human RPMI-2650 cell growth in a cell viability assay, IC50 = 0.009996 μM. |
SANGER |
BHY |
Growth inhibition assay |
|
|
Inhibition of human BHY cell growth in a cell viability assay, IC50 = 0.009946 μM. |
SANGER |
COR-L23 |
Growth inhibition assay |
|
|
Inhibition of human COR-L23 cell growth in a cell viability assay, IC50 = 0.009886 μM. |
SANGER |
MDA-MB-361 |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50 = 0.009759 μM. |
SANGER |
KYSE-450 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-450 cell growth in a cell viability assay, IC50 = 0.009741 μM. |
SANGER |
LOUCY |
Growth inhibition assay |
|
|
Inhibition of human LOUCY cell growth in a cell viability assay, IC50 = 0.009689 μM. |
SANGER |
SU-DHL-1 |
Growth inhibition assay |
|
|
Inhibition of human SU-DHL-1 cell growth in a cell viability assay, IC50 = 0.009451 μM. |
SANGER |
BC-1 |
Growth inhibition assay |
|
|
Inhibition of human BC-1 cell growth in a cell viability assay, IC50 = 0.009391 μM. |
SANGER |
KU812 |
Growth inhibition assay |
|
|
Inhibition of human KU812 cell growth in a cell viability assay, IC50 = 0.009301 μM. |
SANGER |
MC-CAR |
Growth inhibition assay |
|
|
Inhibition of human MC-CAR cell growth in a cell viability assay, IC50 = 0.009274 μM. |
SANGER |
TE-11 |
Growth inhibition assay |
|
|
Inhibition of human TE-11 cell growth in a cell viability assay, IC50 = 0.009155 μM. |
SANGER |
ESS-1 |
Growth inhibition assay |
|
|
Inhibition of human ESS-1 cell growth in a cell viability assay, IC50 = 0.009136 μM. |
SANGER |
KM-H2 |
Growth inhibition assay |
|
|
Inhibition of human KM-H2 cell growth in a cell viability assay, IC50 = 0.009108 μM. |
SANGER |
EoL-1-cell |
Growth inhibition assay |
|
|
Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50 = 0.009086 μM. |
SANGER |
SK-NEP-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-NEP-1 cell growth in a cell viability assay, IC50 = 0.00899 μM. |
SANGER |
HH |
Growth inhibition assay |
|
|
Inhibition of human HH cell growth in a cell viability assay, IC50 = 0.008879 μM. |
SANGER |
RPMI-7951 |
Growth inhibition assay |
|
|
Inhibition of human RPMI-7951 cell growth in a cell viability assay, IC50 = 0.008815 μM. |
SANGER |
22RV1 |
Growth inhibition assay |
|
|
Inhibition of human 22RV1 cell growth in a cell viability assay, IC50 = 0.008787 μM. |
SANGER |
SCC-15 |
Growth inhibition assay |
|
|
Inhibition of human SCC-15 cell growth in a cell viability assay, IC50 = 0.008695 μM. |
SANGER |
NCI-H526 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H526 cell growth in a cell viability assay, IC50 = 0.008675 μM. |
SANGER |
A101D |
Growth inhibition assay |
|
|
Inhibition of human A101D cell growth in a cell viability assay, IC50 = 0.008674 μM. |
SANGER |
CAL-51 |
Growth inhibition assay |
|
|
Inhibition of human CAL-51 cell growth in a cell viability assay, IC50 = 0.008613 μM. |
SANGER |
LB771-HNC |
Growth inhibition assay |
|
|
Inhibition of human LB771-HNC cell growth in a cell viability assay, IC50 = 0.008591 μM. |
SANGER |
SW620 |
Growth inhibition assay |
|
|
Inhibition of human SW620 cell growth in a cell viability assay, IC50 = 0.008523 μM. |
SANGER |
SK-CO-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-CO-1 cell growth in a cell viability assay, IC50 = 0.008497 μM. |
SANGER |
NCI-H2009 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50 = 0.008458 μM. |
SANGER |
SK-OV-3 |
Growth inhibition assay |
|
|
Inhibition of human SK-OV-3 cell growth in a cell viability assay, IC50 = 0.008386 μM. |
SANGER |
CCF-STTG1 |
Growth inhibition assay |
|
|
Inhibition of human CCF-STTG1 cell growth in a cell viability assay, IC50 = 0.008373 μM. |
SANGER |
GR-ST |
Growth inhibition assay |
|
|
Inhibition of human GR-ST cell growth in a cell viability assay, IC50 = 0.008272 μM. |
SANGER |
NCI-H2087 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2087 cell growth in a cell viability assay, IC50 = 0.008218 μM. |
SANGER |
AU565 |
Growth inhibition assay |
|
|
Inhibition of human AU565 cell growth in a cell viability assay, IC50 = 0.008185 μM. |
SANGER |
CAL-62 |
Growth inhibition assay |
|
|
Inhibition of human CAL-62 cell growth in a cell viability assay, IC50 = 0.008183 μM. |
SANGER |
NY |
Growth inhibition assay |
|
|
Inhibition of human NY cell growth in a cell viability assay, IC50 = 0.008123 μM. |
SANGER |
KNS-42 |
Growth inhibition assay |
|
|
Inhibition of human KNS-42 cell growth in a cell viability assay, IC50 = 0.008028 μM. |
SANGER |
RS4-11 |
Growth inhibition assay |
|
|
Inhibition of human RS4-11 cell growth in a cell viability assay, IC50 = 0.00799 μM. |
SANGER |
LoVo |
Growth inhibition assay |
|
|
Inhibition of human LoVo cell growth in a cell viability assay, IC50 = 0.007902 μM. |
SANGER |
G-401 |
Growth inhibition assay |
|
|
Inhibition of human G-401 cell growth in a cell viability assay, IC50 = 0.007874 μM. |
SANGER |
H4 |
Growth inhibition assay |
|
|
Inhibition of human H4 cell growth in a cell viability assay, IC50 = 0.007851 μM. |
SANGER |
GP5d |
Growth inhibition assay |
|
|
Inhibition of human GP5d cell growth in a cell viability assay, IC50 = 0.007841 μM. |
SANGER |
SNU-C2B |
Growth inhibition assay |
|
|
Inhibition of human SNU-C2B cell growth in a cell viability assay, IC50 = 0.007749 μM. |
SANGER |
5637 |
Growth inhibition assay |
|
|
Inhibition of human 5637 cell growth in a cell viability assay, IC50 = 0.007552 μM. |
SANGER |
Detroit562 |
Growth inhibition assay |
|
|
Inhibition of human Detroit562 cell growth in a cell viability assay, IC50 = 0.007549 μM. |
SANGER |
C-33-A |
Growth inhibition assay |
|
|
Inhibition of human C-33-A cell growth in a cell viability assay, IC50 = 0.007314 μM. |
SANGER |
NCI-H64 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H64 cell growth in a cell viability assay, IC50 = 0.007273 μM. |
SANGER |
A673 |
Growth inhibition assay |
|
|
Inhibition of human A673 cell growth in a cell viability assay, IC50 = 0.007268 μM. |
SANGER |
REH |
Growth inhibition assay |
|
|
Inhibition of human REH cell growth in a cell viability assay, IC50 = 0.007207 μM. |
SANGER |
TUR |
Growth inhibition assay |
|
|
Inhibition of human TUR cell growth in a cell viability assay, IC50 = 0.007198 μM. |
SANGER |
LC4-1 |
Growth inhibition assay |
|
|
Inhibition of human LC4-1 cell growth in a cell viability assay, IC50 = 0.007188 μM. |
SANGER |
SK-MEL-2 |
Growth inhibition assay |
|
|
Inhibition of human SK-MEL-2 cell growth in a cell viability assay, IC50 = 0.007183 μM. |
SANGER |
MDA-MB-468 |
Growth inhibition assay |
|
|
Inhibition of human MDA-MB-468 cell growth in a cell viability assay, IC50 = 0.007137 μM. |
SANGER |
KYSE-180 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-180 cell growth in a cell viability assay, IC50 = 0.007134 μM. |
SANGER |
RL95-2 |
Growth inhibition assay |
|
|
Inhibition of human RL95-2 cell growth in a cell viability assay, IC50 = 0.007132 μM. |
SANGER |
NCI-H1437 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1437 cell growth in a cell viability assay, IC50 = 0.007111 μM. |
SANGER |
HuO9 |
Growth inhibition assay |
|
|
Inhibition of human HuO9 cell growth in a cell viability assay, IC50 = 0.007092 μM. |
SANGER |
KGN |
Growth inhibition assay |
|
|
Inhibition of human KGN cell growth in a cell viability assay, IC50 = 0.007051 μM. |
SANGER |
EW-18 |
Growth inhibition assay |
|
|
Inhibition of human EW-18 cell growth in a cell viability assay, IC50 = 0.007046 μM. |
SANGER |
RPMI-8866 |
Growth inhibition assay |
|
|
Inhibition of human RPMI-8866 cell growth in a cell viability assay, IC50 = 0.006997 μM. |
SANGER |
NCI-H460 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50 = 0.006983 μM. |
SANGER |
23132-87 |
Growth inhibition assay |
|
|
Inhibition of human 23132-87 cell growth in a cell viability assay, IC50 = 0.006945 μM. |
SANGER |
ETK-1 |
Growth inhibition assay |
|
|
Inhibition of human ETK-1 cell growth in a cell viability assay, IC50 = 0.006921 μM. |
SANGER |
LB647-SCLC |
Growth inhibition assay |
|
|
Inhibition of human LB647-SCLC cell growth in a cell viability assay, IC50 = 0.006889 μM. |
SANGER |
U251 |
Growth inhibition assay |
|
|
Inhibition of human U251 cell growth in a cell viability assay, IC50 = 0.006887 μM. |
SANGER |
MHH-PREB-1 |
Growth inhibition assay |
|
|
Inhibition of human MHH-PREB-1 cell growth in a cell viability assay, IC50 = 0.006884 μM. |
SANGER |
RPMI-6666 |
Growth inhibition assay |
|
|
Inhibition of human RPMI-6666 cell growth in a cell viability assay, IC50 = 0.006862 μM. |
SANGER |
J-RT3-T3-5 |
Growth inhibition assay |
|
|
Inhibition of human J-RT3-T3-5 cell growth in a cell viability assay, IC50 = 0.006831 μM. |
SANGER |
EB2 |
Growth inhibition assay |
|
|
Inhibition of human EB2 cell growth in a cell viability assay, IC50 = 0.0067 μM. |
SANGER |
ChaGo-K-1 |
Growth inhibition assay |
|
|
Inhibition of human ChaGo-K-1 cell growth in a cell viability assay, IC50 = 0.006686 μM. |
SANGER |
MOLT-4 |
Growth inhibition assay |
|
|
Inhibition of human MOLT-4 cell growth in a cell viability assay, IC50 = 0.006659 μM. |
SANGER |
HO-1-N-1 |
Growth inhibition assay |
|
|
Inhibition of human HO-1-N-1 cell growth in a cell viability assay, IC50 = 0.006652 μM. |
SANGER |
Daoy |
Growth inhibition assay |
|
|
Inhibition of human Daoy cell growth in a cell viability assay, IC50 = 0.006646 μM. |
SANGER |
EW-13 |
Growth inhibition assay |
|
|
Inhibition of human EW-13 cell growth in a cell viability assay, IC50 = 0.006617 μM. |
SANGER |
639-V |
Growth inhibition assay |
|
|
Inhibition of human 639-V cell growth in a cell viability assay, IC50 = 0.006609 μM. |
SANGER |
OVCAR-8 |
Growth inhibition assay |
|
|
Inhibition of human OVCAR-8 cell growth in a cell viability assay, IC50 = 0.006601 μM. |
SANGER |
AGS |
Growth inhibition assay |
|
|
Inhibition of human AGS cell growth in a cell viability assay, IC50 = 0.006462 μM. |
SANGER |
A2780 |
Growth inhibition assay |
|
|
Inhibition of human A2780 cell growth in a cell viability assay, IC50 = 0.006382 μM. |
SANGER |
NCI-H69 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H69 cell growth in a cell viability assay, IC50 = 0.006345 μM. |
SANGER |
OPM-2 |
Growth inhibition assay |
|
|
Inhibition of human OPM-2 cell growth in a cell viability assay, IC50 = 0.006273 μM. |
SANGER |
AN3-CA |
Growth inhibition assay |
|
|
Inhibition of human AN3-CA cell growth in a cell viability assay, IC50 = 0.006269 μM. |
SANGER |
LU-99A |
Growth inhibition assay |
|
|
Inhibition of human LU-99A cell growth in a cell viability assay, IC50 = 0.006239 μM. |
SANGER |
KYSE-410 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-410 cell growth in a cell viability assay, IC50 = 0.006213 μM. |
SANGER |
OVCAR-3 |
Growth inhibition assay |
|
|
Inhibition of human OVCAR-3 cell growth in a cell viability assay, IC50 = 0.00621 μM. |
SANGER |
A388 |
Growth inhibition assay |
|
|
Inhibition of human A388 cell growth in a cell viability assay, IC50 = 0.006067 μM. |
SANGER |
EFM-19 |
Growth inhibition assay |
|
|
Inhibition of human EFM-19 cell growth in a cell viability assay, IC50 = 0.006035 μM. |
SANGER |
NUGC-3 |
Growth inhibition assay |
|
|
Inhibition of human NUGC-3 cell growth in a cell viability assay, IC50 = 0.005992 μM. |
SANGER |
MFE-296 |
Growth inhibition assay |
|
|
Inhibition of human MFE-296 cell growth in a cell viability assay, IC50 = 0.005989 μM. |
SANGER |
SW954 |
Growth inhibition assay |
|
|
Inhibition of human SW954 cell growth in a cell viability assay, IC50 = 0.005983 μM. |
SANGER |
PANC-03-27 |
Growth inhibition assay |
|
|
Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50 = 0.005948 μM. |
SANGER |
NALM-6 |
Growth inhibition assay |
|
|
Inhibition of human NALM-6 cell growth in a cell viability assay, IC50 = 0.00594 μM. |
SANGER |
NCI-H358 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H358 cell growth in a cell viability assay, IC50 = 0.005888 μM. |
SANGER |
SR |
Growth inhibition assay |
|
|
Inhibition of human SR cell growth in a cell viability assay, IC50 = 0.005842 μM. |
SANGER |
MIA-PaCa-2 |
Growth inhibition assay |
|
|
Inhibition of human MIA-PaCa-2 cell growth in a cell viability assay, IC50 = 0.005828 μM. |
SANGER |
SW48 |
Growth inhibition assay |
|
|
Inhibition of human SW48 cell growth in a cell viability assay, IC50 = 0.0058 μM. |
SANGER |
EFO-27 |
Growth inhibition assay |
|
|
Inhibition of human EFO-27 cell growth in a cell viability assay, IC50 = 0.00579 μM. |
SANGER |
GI-ME-N |
Growth inhibition assay |
|
|
Inhibition of human GI-ME-N cell growth in a cell viability assay, IC50 = 0.005755 μM. |
SANGER |
KARPAS-45 |
Growth inhibition assay |
|
|
Inhibition of human KARPAS-45 cell growth in a cell viability assay, IC50 = 0.005735 μM. |
SANGER |
SK-MES-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-MES-1 cell growth in a cell viability assay, IC50 = 0.005725 μM. |
SANGER |
Calu-6 |
Growth inhibition assay |
|
|
Inhibition of human Calu-6 cell growth in a cell viability assay, IC50 = 0.005701 μM. |
SANGER |
SW872 |
Growth inhibition assay |
|
|
Inhibition of human SW872 cell growth in a cell viability assay, IC50 = 0.00565 μM. |
SANGER |
HSC-3 |
Growth inhibition assay |
|
|
Inhibition of human HSC-3 cell growth in a cell viability assay, IC50 = 0.005619 μM. |
SANGER |
MFH-ino |
Growth inhibition assay |
|
|
Inhibition of human MFH-ino cell growth in a cell viability assay, IC50 = 0.005596 μM. |
SANGER |
SNU-423 |
Growth inhibition assay |
|
|
Inhibition of human SNU-423 cell growth in a cell viability assay, IC50 = 0.00554 μM. |
SANGER |
NCI-H1770 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50 = 0.005534 μM. |
SANGER |
RD |
Growth inhibition assay |
|
|
Inhibition of human RD cell growth in a cell viability assay, IC50 = 0.005425 μM. |
SANGER |
NCCIT |
Growth inhibition assay |
|
|
Inhibition of human NCCIT cell growth in a cell viability assay, IC50 = 0.005419 μM. |
SANGER |
Becker |
Growth inhibition assay |
|
|
Inhibition of human Becker cell growth in a cell viability assay, IC50 = 0.005391 μM. |
SANGER |
SW982 |
Growth inhibition assay |
|
|
Inhibition of human SW982 cell growth in a cell viability assay, IC50 = 0.005298 μM. |
SANGER |
BL-41 |
Growth inhibition assay |
|
|
Inhibition of human BL-41 cell growth in a cell viability assay, IC50 = 0.00528 μM. |
SANGER |
RXF393 |
Growth inhibition assay |
|
|
Inhibition of human RXF393 cell growth in a cell viability assay, IC50 = 0.005065 μM. |
SANGER |
NCI-H292 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H292 cell growth in a cell viability assay, IC50 = 0.005053 μM. |
SANGER |
HCC2998 |
Growth inhibition assay |
|
|
Inhibition of human HCC2998 cell growth in a cell viability assay, IC50 = 0.005045 μM. |
SANGER |
CESS |
Growth inhibition assay |
|
|
Inhibition of human CESS cell growth in a cell viability assay, IC50 = 0.005043 μM. |
SANGER |
DOHH-2 |
Growth inhibition assay |
|
|
Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50 = 0.005039 μM. |
SANGER |
CAL-33 |
Growth inhibition assay |
|
|
Inhibition of human CAL-33 cell growth in a cell viability assay, IC50 = 0.005021 μM. |
SANGER |
NB13 |
Growth inhibition assay |
|
|
Inhibition of human NB13 cell growth in a cell viability assay, IC50 = 0.005014 μM. |
SANGER |
MCF7 |
Growth inhibition assay |
|
|
Inhibition of human MCF7 cell growth in a cell viability assay, IC50 = 0.005011 μM. |
SANGER |
CTV-1 |
Growth inhibition assay |
|
|
Inhibition of human CTV-1 cell growth in a cell viability assay, IC50 = 0.005011 μM. |
SANGER |
LC-2-ad |
Growth inhibition assay |
|
|
Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50 = 0.004977 μM. |
SANGER |
NKM-1 |
Growth inhibition assay |
|
|
Inhibition of human NKM-1 cell growth in a cell viability assay, IC50 = 0.004972 μM. |
SANGER |
HCC1569 |
Growth inhibition assay |
|
|
Inhibition of human HCC1569 cell growth in a cell viability assay, IC50 = 0.004932 μM. |
SANGER |
8305C |
Growth inhibition assay |
|
|
Inhibition of human 8305C cell growth in a cell viability assay, IC50 = 0.004919 μM. |
SANGER |
CAL-85-1 |
Growth inhibition assay |
|
|
Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50 = 0.004904 μM. |
SANGER |
HCC38 |
Growth inhibition assay |
|
|
Inhibition of human HCC38 cell growth in a cell viability assay, IC50 = 0.004872 μM. |
SANGER |
DSH1 |
Growth inhibition assay |
|
|
Inhibition of human DSH1 cell growth in a cell viability assay, IC50 = 0.004868 μM. |
SANGER |
DU-145 |
Growth inhibition assay |
|
|
Inhibition of human DU-145 cell growth in a cell viability assay, IC50 = 0.004814 μM. |
SANGER |
NCI-H2342 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50 = 0.004785 μM. |
SANGER |
MKN28 |
Growth inhibition assay |
|
|
Inhibition of human MKN28 cell growth in a cell viability assay, IC50 = 0.004771 μM. |
SANGER |
HMV-II |
Growth inhibition assay |
|
|
Inhibition of human HMV-II cell growth in a cell viability assay, IC50 = 0.004768 μM. |
SANGER |
SUP-T1 |
Growth inhibition assay |
|
|
Inhibition of human SUP-T1 cell growth in a cell viability assay, IC50 = 0.004719 μM. |
SANGER |
SW13 |
Growth inhibition assay |
|
|
Inhibition of human SW13 cell growth in a cell viability assay, IC50 = 0.004717 μM. |
SANGER |
LXF-289 |
Growth inhibition assay |
|
|
Inhibition of human LXF-289 cell growth in a cell viability assay, IC50 = 0.004685 μM. |
SANGER |
CHL-1 |
Growth inhibition assay |
|
|
Inhibition of human CHL-1 cell growth in a cell viability assay, IC50 = 0.004595 μM. |
SANGER |
CCRF-CEM |
Growth inhibition assay |
|
|
Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50 = 0.004555 μM. |
SANGER |
SK-HEP-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-HEP-1 cell growth in a cell viability assay, IC50 = 0.004517 μM. |
SANGER |
MRK-nu-1 |
Growth inhibition assay |
|
|
Inhibition of human MRK-nu-1 cell growth in a cell viability assay, IC50 = 0.004474 μM. |
SANGER |
Ramos-2G6-4C10 |
Growth inhibition assay |
|
|
Inhibition of human Ramos-2G6-4C10 cell growth in a cell viability assay, IC50 = 0.004452 μM. |
SANGER |
OCUB-M |
Growth inhibition assay |
|
|
Inhibition of human OCUB-M cell growth in a cell viability assay, IC50 = 0.004433 μM. |
SANGER |
KE-37 |
Growth inhibition assay |
|
|
Inhibition of human KE-37 cell growth in a cell viability assay, IC50 = 0.00442 μM. |
SANGER |
8505C |
Growth inhibition assay |
|
|
Inhibition of human 8505C cell growth in a cell viability assay, IC50 = 0.004419 μM. |
SANGER |
EW-16 |
Growth inhibition assay |
|
|
Inhibition of human EW-16 cell growth in a cell viability assay, IC50 = 0.004348 μM. |
SANGER |
ML-2 |
Growth inhibition assay |
|
|
Inhibition of human ML-2 cell growth in a cell viability assay, IC50 = 0.004323 μM. |
SANGER |
CAL-39 |
Growth inhibition assay |
|
|
Inhibition of human CAL-39 cell growth in a cell viability assay, IC50 = 0.004258 μM. |
SANGER |
MEL-JUSO |
Growth inhibition assay |
|
|
Inhibition of human MEL-JUSO cell growth in a cell viability assay, IC50 = 0.004255 μM. |
SANGER |
VA-ES-BJ |
Growth inhibition assay |
|
|
Inhibition of human VA-ES-BJ cell growth in a cell viability assay, IC50 = 0.004233 μM. |
SANGER |
697 |
Growth inhibition assay |
|
|
Inhibition of human 697 cell growth in a cell viability assay, IC50 = 0.004228 μM. |
SANGER |
KYSE-510 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-510 cell growth in a cell viability assay, IC50 = 0.004188 μM. |
SANGER |
A4-Fuk |
Growth inhibition assay |
|
|
Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50 = 0.004035 μM. |
SANGER |
EW-1 |
Growth inhibition assay |
|
|
Inhibition of human EW-1 cell growth in a cell viability assay, IC50 = 0.003934 μM. |
SANGER |
NCI-H1648 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50 = 0.00392 μM. |
SANGER |
NCI-H810 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H810 cell growth in a cell viability assay, IC50 = 0.003908 μM. |
SANGER |
BxPC-3 |
Growth inhibition assay |
|
|
Inhibition of human BxPC-3 cell growth in a cell viability assay, IC50 = 0.003901 μM. |
SANGER |
KALS-1 |
Growth inhibition assay |
|
|
Inhibition of human KALS-1 cell growth in a cell viability assay, IC50 = 0.003897 μM. |
SANGER |
MHH-ES-1 |
Growth inhibition assay |
|
|
Inhibition of human MHH-ES-1 cell growth in a cell viability assay, IC50 = 0.003894 μM. |
SANGER |
HC-1 |
Growth inhibition assay |
|
|
Inhibition of human HC-1 cell growth in a cell viability assay, IC50 = 0.003887 μM. |
SANGER |
DBTRG-05MG |
Growth inhibition assay |
|
|
Inhibition of human DBTRG-05MG cell growth in a cell viability assay, IC50 = 0.003885 μM. |
SANGER |
SNG-M |
Growth inhibition assay |
|
|
Inhibition of human SNG-M cell growth in a cell viability assay, IC50 = 0.003883 μM. |
SANGER |
RVH-421 |
Growth inhibition assay |
|
|
Inhibition of human RVH-421 cell growth in a cell viability assay, IC50 = 0.003881 μM. |
SANGER |
ES7 |
Growth inhibition assay |
|
|
Inhibition of human ES7 cell growth in a cell viability assay, IC50 = 0.003856 μM. |
SANGER |
ES1 |
Growth inhibition assay |
|
|
Inhibition of human ES1 cell growth in a cell viability assay, IC50 = 0.003778 μM. |
SANGER |
YKG-1 |
Growth inhibition assay |
|
|
Inhibition of human YKG-1 cell growth in a cell viability assay, IC50 = 0.00373 μM. |
SANGER |
IA-LM |
Growth inhibition assay |
|
|
Inhibition of human IA-LM cell growth in a cell viability assay, IC50 = 0.003713 μM. |
SANGER |
DEL |
Growth inhibition assay |
|
|
Inhibition of human DEL cell growth in a cell viability assay, IC50 = 0.00363 μM. |
SANGER |
TE-10 |
Growth inhibition assay |
|
|
Inhibition of human TE-10 cell growth in a cell viability assay, IC50 = 0.003625 μM. |
SANGER |
BFTC-905 |
Growth inhibition assay |
|
|
Inhibition of human BFTC-905 cell growth in a cell viability assay, IC50 = 0.003622 μM. |
SANGER |
NCI-H2030 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2030 cell growth in a cell viability assay, IC50 = 0.003618 μM. |
SANGER |
DoTc2-4510 |
Growth inhibition assay |
|
|
Inhibition of human DoTc2-4510 cell growth in a cell viability assay, IC50 = 0.003593 μM. |
SANGER |
GI-1 |
Growth inhibition assay |
|
|
Inhibition of human GI-1 cell growth in a cell viability assay, IC50 = 0.003536 μM. |
SANGER |
G-361 |
Growth inhibition assay |
|
|
Inhibition of human G-361 cell growth in a cell viability assay, IC50 = 0.003525 μM. |
SANGER |
PANC-10-05 |
Growth inhibition assay |
|
|
Inhibition of human PANC-10-05 cell growth in a cell viability assay, IC50 = 0.003525 μM. |
SANGER |
A2058 |
Growth inhibition assay |
|
|
Inhibition of human A2058 cell growth in a cell viability assay, IC50 = 0.003503 μM. |
SANGER |
8-MG-BA |
Growth inhibition assay |
|
|
Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50 = 0.003375 μM. |
SANGER |
HCT-116 |
Growth inhibition assay |
|
|
Inhibition of human HCT-116 cell growth in a cell viability assay, IC50 = 0.003373 μM. |
SANGER |
RT-112 |
Growth inhibition assay |
|
|
Inhibition of human RT-112 cell growth in a cell viability assay, IC50 = 0.003371 μM. |
SANGER |
ALL-PO |
Growth inhibition assay |
|
|
Inhibition of human ALL-PO cell growth in a cell viability assay, IC50 = 0.003359 μM. |
SANGER |
ONS-76 |
Growth inhibition assay |
|
|
Inhibition of human ONS-76 cell growth in a cell viability assay, IC50 = 0.0033 μM. |
SANGER |
MEL-HO |
Growth inhibition assay |
|
|
Inhibition of human MEL-HO cell growth in a cell viability assay, IC50 = 0.003291 μM. |
SANGER |
PC-14 |
Growth inhibition assay |
|
|
Inhibition of human PC-14 cell growth in a cell viability assay, IC50 = 0.00326 μM. |
SANGER |
HT-29 |
Growth inhibition assay |
|
|
Inhibition of human HT-29 cell growth in a cell viability assay, IC50 = 0.003236 μM. |
SANGER |
HOS |
Growth inhibition assay |
|
|
Inhibition of human HOS cell growth in a cell viability assay, IC50 = 0.003218 μM. |
SANGER |
A204 |
Growth inhibition assay |
|
|
Inhibition of human A204 cell growth in a cell viability assay, IC50 = 0.003208 μM. |
SANGER |
LS-411N |
Growth inhibition assay |
|
|
Inhibition of human LS-411N cell growth in a cell viability assay, IC50 = 0.003171 μM. |
SANGER |
BL-70 |
Growth inhibition assay |
|
|
Inhibition of human BL-70 cell growth in a cell viability assay, IC50 = 0.003164 μM. |
SANGER |
KYSE-270 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-270 cell growth in a cell viability assay, IC50 = 0.003156 μM. |
SANGER |
PA-1 |
Growth inhibition assay |
|
|
Inhibition of human PA-1 cell growth in a cell viability assay, IC50 = 0.003123 μM. |
SANGER |
MES-SA |
Growth inhibition assay |
|
|
Inhibition of human MES-SA cell growth in a cell viability assay, IC50 = 0.003115 μM. |
SANGER |
TE-15 |
Growth inhibition assay |
|
|
Inhibition of human TE-15 cell growth in a cell viability assay, IC50 = 0.003103 μM. |
SANGER |
A427 |
Growth inhibition assay |
|
|
Inhibition of human A427 cell growth in a cell viability assay, IC50 = 0.003103 μM. |
SANGER |
QIMR-WIL |
Growth inhibition assay |
|
|
Inhibition of human QIMR-WIL cell growth in a cell viability assay, IC50 = 0.003043 μM. |
SANGER |
KYSE-150 |
Growth inhibition assay |
|
|
Inhibition of human KYSE-150 cell growth in a cell viability assay, IC50 = 0.003039 μM. |
SANGER |
ABC-1 |
Growth inhibition assay |
|
|
Inhibition of human ABC-1 cell growth in a cell viability assay, IC50 = 0.003024 μM. |
SANGER |
786-0 |
Growth inhibition assay |
|
|
Inhibition of human 786-0 cell growth in a cell viability assay, IC50 = 0.002992 μM. |
SANGER |
BCPAP |
Growth inhibition assay |
|
|
Inhibition of human BCPAP cell growth in a cell viability assay, IC50 = 0.002978 μM. |
SANGER |
ST486 |
Growth inhibition assay |
|
|
Inhibition of human ST486 cell growth in a cell viability assay, IC50 = 0.002957 μM. |
SANGER |
MG-63 |
Growth inhibition assay |
|
|
Inhibition of human MG-63 cell growth in a cell viability assay, IC50 = 0.002938 μM. |
SANGER |
NCI-H1355 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1355 cell growth in a cell viability assay, IC50 = 0.0029 μM. |
SANGER |
A431 |
Growth inhibition assay |
|
|
Inhibition of human A431 cell growth in a cell viability assay, IC50 = 0.002897 μM. |
SANGER |
NCI-H1703 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1703 cell growth in a cell viability assay, IC50 = 0.002834 μM. |
SANGER |
KURAMOCHI |
Growth inhibition assay |
|
|
Inhibition of human KURAMOCHI cell growth in a cell viability assay, IC50 = 0.002814 μM. |
SANGER |
HuCCT1 |
Growth inhibition assay |
|
|
Inhibition of human HuCCT1 cell growth in a cell viability assay, IC50 = 0.002778 μM. |
SANGER |
ES8 |
Growth inhibition assay |
|
|
Inhibition of human ES8 cell growth in a cell viability assay, IC50 = 0.002719 μM. |
SANGER |
KP-4 |
Growth inhibition assay |
|
|
Inhibition of human KP-4 cell growth in a cell viability assay, IC50 = 0.002711 μM. |
SANGER |
DMS-273 |
Growth inhibition assay |
|
|
Inhibition of human DMS-273 cell growth in a cell viability assay, IC50 = 0.002707 μM. |
SANGER |
KM12 |
Growth inhibition assay |
|
|
Inhibition of human KM12 cell growth in a cell viability assay, IC50 = 0.002606 μM. |
SANGER |
NCI-H2122 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2122 cell growth in a cell viability assay, IC50 = 0.002588 μM. |
SANGER |
SCC-4 |
Growth inhibition assay |
|
|
Inhibition of human SCC-4 cell growth in a cell viability assay, IC50 = 0.002585 μM. |
SANGER |
HT-1080 |
Growth inhibition assay |
|
|
Inhibition of human HT-1080 cell growth in a cell viability assay, IC50 = 0.002495 μM. |
SANGER |
SIG-M5 |
Growth inhibition assay |
|
|
Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50 = 0.002476 μM. |
SANGER |
SW1710 |
Growth inhibition assay |
|
|
Inhibition of human SW1710 cell growth in a cell viability assay, IC50 = 0.002334 μM. |
SANGER |
MKN45 |
Growth inhibition assay |
|
|
Inhibition of human MKN45 cell growth in a cell viability assay, IC50 = 0.002287 μM. |
SANGER |
HSC-2 |
Growth inhibition assay |
|
|
Inhibition of human HSC-2 cell growth in a cell viability assay, IC50 = 0.00225 μM. |
SANGER |
SK-UT-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50 = 0.002234 μM. |
SANGER |
IGROV-1 |
Growth inhibition assay |
|
|
Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50 = 0.002202 μM. |
SANGER |
HUTU-80 |
Growth inhibition assay |
|
|
Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50 = 0.002177 μM. |
SANGER |
NB12 |
Growth inhibition assay |
|
|
Inhibition of human NB12 cell growth in a cell viability assay, IC50 = 0.002111 μM. |
SANGER |
SBC-5 |
Growth inhibition assay |
|
|
Inhibition of human SBC-5 cell growth in a cell viability assay, IC50 = 0.002082 μM. |
SANGER |
SCC-9 |
Growth inhibition assay |
|
|
Inhibition of human SCC-9 cell growth in a cell viability assay, IC50 = 0.002046 μM. |
SANGER |
ATN-1 |
Growth inhibition assay |
|
|
Inhibition of human ATN-1 cell growth in a cell viability assay, IC50 = 0.001943 μM. |
SANGER |
HOP-62 |
Growth inhibition assay |
|
|
Inhibition of human HOP-62 cell growth in a cell viability assay, IC50 = 0.001927 μM. |
SANGER |
IGR-1 |
Growth inhibition assay |
|
|
Inhibition of human IGR-1 cell growth in a cell viability assay, IC50 = 0.001903 μM. |
SANGER |
BPH-1 |
Growth inhibition assay |
|
|
Inhibition of human BPH-1 cell growth in a cell viability assay, IC50 = 0.001899 μM. |
SANGER |
NCI-H520 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H520 cell growth in a cell viability assay, IC50 = 0.00187 μM. |
SANGER |
HGC-27 |
Growth inhibition assay |
|
|
Inhibition of human HGC-27 cell growth in a cell viability assay, IC50 = 0.001852 μM. |
SANGER |
COLO-679 |
Growth inhibition assay |
|
|
Inhibition of human COLO-679 cell growth in a cell viability assay, IC50 = 0.001832 μM. |
SANGER |
OVCAR-4 |
Growth inhibition assay |
|
|
Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50 = 0.001745 μM. |
SANGER |
LCLC-97TM1 |
Growth inhibition assay |
|
|
Inhibition of human LCLC-97TM1 cell growth in a cell viability assay, IC50 = 0.001559 μM. |
SANGER |
RKO |
Growth inhibition assay |
|
|
Inhibition of human RKO cell growth in a cell viability assay, IC50 = 0.00152 μM. |
SANGER |
MC-IXC |
Growth inhibition assay |
|
|
Inhibition of human MC-IXC cell growth in a cell viability assay, IC50 = 0.001486 μM. |
SANGER |
KS-1 |
Growth inhibition assay |
|
|
Inhibition of human KS-1 cell growth in a cell viability assay, IC50 = 0.001466 μM. |
SANGER |
SK-LMS-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50 = 0.001461 μM. |
SANGER |
LCLC-103H |
Growth inhibition assay |
|
|
Inhibition of human LCLC-103H cell growth in a cell viability assay, IC50 = 0.001427 μM. |
SANGER |
COLO-205 |
Growth inhibition assay |
|
|
Inhibition of human COLO-205 cell growth in a cell viability assay, IC50 = 0.001368 μM. |
SANGER |
ACN |
Growth inhibition assay |
|
|
Inhibition of human ACN cell growth in a cell viability assay, IC50 = 0.001329 μM. |
SANGER |
A253 |
Growth inhibition assay |
|
|
Inhibition of human A253 cell growth in a cell viability assay, IC50 = 0.001223 μM. |
SANGER |
TE-9 |
Growth inhibition assay |
|
|
Inhibition of human TE-9 cell growth in a cell viability assay, IC50 = 0.001078 μM. |
SANGER |
NTERA-S-cl-D1 |
Growth inhibition assay |
|
|
Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50 = 0.0009386 μM. |
SANGER |
GT3TKB |
Growth inhibition assay |
|
|
Inhibition of human GT3TKB cell growth in a cell viability assay, IC50 = 0.0007477 μM. |
SANGER |
HT-144 |
Growth inhibition assay |
|
|
Inhibition of human HT-144 cell growth in a cell viability assay, IC50 = 0.0005909 μM. |
SANGER |
NCI-H522 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H522 cell growth in a cell viability assay, IC50 = 0.0005354 μM. |
SANGER |
ECC12 |
Growth inhibition assay |
|
|
Inhibition of human ECC12 cell growth in a cell viability assay, IC50 = 0.000509 μM. |
SANGER |
BB30-HNC |
Growth inhibition assay |
|
|
Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50 = 0.0003988 μM. |
SANGER |
CGTH-W-1 |
Growth inhibition assay |
|
|
Inhibition of human CGTH-W-1 cell growth in a cell viability assay, IC50 = 0.0002316 μM. |
SANGER |
COLO-829 |
Growth inhibition assay |
|
|
Inhibition of human COLO-829 cell growth in a cell viability assay, IC50 = 0.0001051 μM. |
SANGER |
NCI/ADR-RES |
Cytotoxicity assay |
|
|
Cytotoxicity against human NCI/ADR-RES cells assessed as growth inhibition by trypan blue exclusion assay, IC50 = 5 μM. |
23214452 |
OVCAR8 |
Cytotoxicity assay |
|
|
Cytotoxicity against human OVCAR8 cells assessed as growth inhibition by trypan blue exclusion assay, IC50 = 0.3 μM. |
23214452 |
A549 |
Cytotoxicity assay |
|
|
Cytotoxicity against human A549 cells by sulforhodamine B assay, IC50 = 0.03 μM. |
19499938 |
HeLa |
Cytotoxicity assay |
|
|
Cytotoxicity against human HeLa cells by MTT assay, IC50 = 0.027 μM. |
22115594 |
HeLa |
Cytotoxicity assay |
|
|
Cytotoxicity against human HeLa cells by sulforhodamine B assay, IC50 = 0.027 μM. |
19499938 |
A549 |
Cytotoxicity assay |
|
|
Cytotoxicity against human A549 cells by MTT assay, IC50 = 0.01 μM. |
22525316 |
HeLa |
Cytotoxicity assay |
|
|
Cytotoxicity against human HeLa cells by MTT assay, IC50 = 0.009 μM. |
22525316 |
HeLa |
Cytotoxicity assay |
|
|
Cytotoxicity against human HeLa cells, GI50 = 0.0027 μM. |
19147348 |
MCF7 |
Cytotoxicity assay |
|
|
Cytotoxicity against human MCF7 cells, GI50 = 0.0024 μM. |
19147348 |
NCI-H1993 |
Function assay |
|
|
the rate of cell death upon capmatinib treatment was largely restricted to inhibition of proliferation |
30674502 |
EBC-1 |
Function assay |
|
|
EBC-1 cells displayed a markedly higher rate of cell death upon capmatinib treatment, albeit not reaching 100%, whereas the effect in NCI-H1993 was largely restricted to inhibition of proliferation |
30674502 |
DMS-79 |
Growth inhibition assay |
|
|
Inhibition of human DMS-79 cell growth in a cell viability assay, IC50 = 0.53781 μM. |
SANGER |
IM-9 |
Growth inhibition assay |
|
|
Inhibition of human IM-9 cell growth in a cell viability assay, IC50 = 0.54557 μM. |
SANGER |
SK-MEL-28 |
Growth inhibition assay |
|
|
Inhibition of human SK-MEL-28 cell growth in a cell viability assay, IC50 = 0.61539 μM. |
SANGER |
CAL-72 |
Growth inhibition assay |
|
|
Inhibition of human CAL-72 cell growth in a cell viability assay, IC50 = 0.61825 μM. |
SANGER |
HSC-4 |
Growth inhibition assay |
|
|
Inhibition of human HSC-4 cell growth in a cell viability assay, IC50 = 0.62725 μM. |
SANGER |
D-283MED |
Growth inhibition assay |
|
|
Inhibition of human D-283MED cell growth in a cell viability assay, IC50 = 0.64284 μM. |
SANGER |
NCI-H596 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H596 cell growth in a cell viability assay, IC50 = 0.65934 μM. |
SANGER |
NCI-H1618 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1618 cell growth in a cell viability assay, IC50 = 0.71488 μM. |
SANGER |
NCI-H1993 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1993 cell growth in a cell viability assay, IC50 = 0.74088 μM. |
SANGER |
RCM-1 |
Growth inhibition assay |
|
|
Inhibition of human RCM-1 cell growth in a cell viability assay, IC50 = 0.7478 μM. |
SANGER |
KNS-81-FD |
Growth inhibition assay |
|
|
Inhibition of human KNS-81-FD cell growth in a cell viability assay, IC50 = 0.8079 μM. |
SANGER |
SK-N-AS |
Growth inhibition assay |
|
|
Inhibition of human SK-N-AS cell growth in a cell viability assay, IC50 = 0.86756 μM. |
SANGER |
SCLC-21H |
Growth inhibition assay |
|
|
Inhibition of human SCLC-21H cell growth in a cell viability assay, IC50 = 0.90851 μM. |
SANGER |
DMS-53 |
Growth inhibition assay |
|
|
Inhibition of human DMS-53 cell growth in a cell viability assay, IC50 = 0.91644 μM. |
SANGER |
UACC-893 |
Growth inhibition assay |
|
|
Inhibition of human UACC-893 cell growth in a cell viability assay, IC50 = 1.09233 μM. |
SANGER |
KU-19-19 |
Growth inhibition assay |
|
|
Inhibition of human KU-19-19 cell growth in a cell viability assay, IC50 = 1.11505 μM. |
SANGER |
C32 |
Growth inhibition assay |
|
|
Inhibition of human C32 cell growth in a cell viability assay, IC50 = 1.11824 μM. |
SANGER |
HCE-T |
Growth inhibition assay |
|
|
Inhibition of human HCE-T cell growth in a cell viability assay, IC50 = 1.15381 μM. |
SANGER |
Saos-2 |
Growth inhibition assay |
|
|
Inhibition of human Saos-2 cell growth in a cell viability assay, IC50 = 1.17363 μM. |
SANGER |
NCI-H2227 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2227 cell growth in a cell viability assay, IC50 = 1.18132 μM. |
SANGER |
Caov-4 |
Growth inhibition assay |
|
|
Inhibition of human Caov-4 cell growth in a cell viability assay, IC50 = 1.22245 μM. |
SANGER |
HCT-15 |
Growth inhibition assay |
|
|
Inhibition of human HCT-15 cell growth in a cell viability assay, IC50 = 1.22304 μM. |
SANGER |
OMC-1 |
Growth inhibition assay |
|
|
Inhibition of human OMC-1 cell growth in a cell viability assay, IC50 = 1.26488 μM. |
SANGER |
CAKI-1 |
Growth inhibition assay |
|
|
Inhibition of human CAKI-1 cell growth in a cell viability assay, IC50 = 1.27128 μM. |
SANGER |
YAPC |
Growth inhibition assay |
|
|
Inhibition of human YAPC cell growth in a cell viability assay, IC50 = 1.28878 μM. |
SANGER |
SK-MM-2 |
Growth inhibition assay |
|
|
Inhibition of human SK-MM-2 cell growth in a cell viability assay, IC50 = 1.34922 μM. |
SANGER |
AsPC-1 |
Growth inhibition assay |
|
|
Inhibition of human AsPC-1 cell growth in a cell viability assay, IC50 = 1.36038 μM. |
SANGER |
RO82-W-1 |
Growth inhibition assay |
|
|
Inhibition of human RO82-W-1 cell growth in a cell viability assay, IC50 = 1.37101 μM. |
SANGER |
LAN-6 |
Growth inhibition assay |
|
|
Inhibition of human LAN-6 cell growth in a cell viability assay, IC50 = 1.42458 μM. |
SANGER |
HN |
Growth inhibition assay |
|
|
Inhibition of human HN cell growth in a cell viability assay, IC50 = 1.43413 μM. |
SANGER |
SK-MEL-1 |
Growth inhibition assay |
|
|
Inhibition of human SK-MEL-1 cell growth in a cell viability assay, IC50 = 1.51819 μM. |
SANGER |
U031 |
Growth inhibition assay |
|
|
Inhibition of human U031 cell growth in a cell viability assay, IC50 = 1.55775 μM. |
SANGER |
HT55 |
Growth inhibition assay |
|
|
Inhibition of human HT55 cell growth in a cell viability assay, IC50 = 1.72747 μM. |
SANGER |
SCC-3 |
Growth inhibition assay |
|
|
Inhibition of human SCC-3 cell growth in a cell viability assay, IC50 = 1.7531 μM. |
SANGER |
SK-MEL-24 |
Growth inhibition assay |
|
|
Inhibition of human SK-MEL-24 cell growth in a cell viability assay, IC50 = 1.7671 μM. |
SANGER |
NCI-H2452 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H2452 cell growth in a cell viability assay, IC50 = 2.0176 μM. |
SANGER |
TT |
Growth inhibition assay |
|
|
Inhibition of human TT cell growth in a cell viability assay, IC50 = 2.27099 μM. |
SANGER |
LS-123 |
Growth inhibition assay |
|
|
Inhibition of human LS-123 cell growth in a cell viability assay, IC50 = 2.33753 μM. |
SANGER |
Hs-578-T |
Growth inhibition assay |
|
|
Inhibition of human Hs-578-T cell growth in a cell viability assay, IC50 = 2.45525 μM. |
SANGER |
SBC-1 |
Growth inhibition assay |
|
|
Inhibition of human SBC-1 cell growth in a cell viability assay, IC50 = 2.56462 μM. |
SANGER |
SCH |
Growth inhibition assay |
|
|
Inhibition of human SCH cell growth in a cell viability assay, IC50 = 3.18837 μM. |
SANGER |
RCC10RGB |
Growth inhibition assay |
|
|
Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50 = 3.29613 μM. |
SANGER |
K-562 |
Growth inhibition assay |
|
|
Inhibition of human K-562 cell growth in a cell viability assay, IC50 = 3.29943 μM. |
SANGER |
SK-N-FI |
Growth inhibition assay |
|
|
Inhibition of human SK-N-FI cell growth in a cell viability assay, IC50 = 3.72776 μM. |
SANGER |
HAL-01 |
Growth inhibition assay |
|
|
Inhibition of human HAL-01 cell growth in a cell viability assay, IC50 = 3.94137 μM. |
SANGER |
ES5 |
Growth inhibition assay |
|
|
Inhibition of human ES5 cell growth in a cell viability assay, IC50 = 4.15835 μM. |
SANGER |
MFM-223 |
Growth inhibition assay |
|
|
Inhibition of human MFM-223 cell growth in a cell viability assay, IC50 = 4.20908 μM. |
SANGER |
NCI-H716 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H716 cell growth in a cell viability assay, IC50 = 4.37889 μM. |
SANGER |
SAS |
Growth inhibition assay |
|
|
Inhibition of human SAS cell growth in a cell viability assay, IC50 = 4.39125 μM. |
SANGER |
PSN1 |
Growth inhibition assay |
|
|
Inhibition of human PSN1 cell growth in a cell viability assay, IC50 = 4.44423 μM. |
SANGER |
A704 |
Growth inhibition assay |
|
|
Inhibition of human A704 cell growth in a cell viability assay, IC50 = 5.84137 μM. |
SANGER |
NCI-H719 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H719 cell growth in a cell viability assay, IC50 = 5.90333 μM. |
SANGER |
U-2-OS |
Growth inhibition assay |
|
|
Inhibition of human U-2-OS cell growth in a cell viability assay, IC50 = 6.30268 μM. |
SANGER |
NCI-H322M |
Growth inhibition assay |
|
|
Inhibition of human NCI-H322M cell growth in a cell viability assay, IC50 = 6.40749 μM. |
SANGER |
DK-MG |
Growth inhibition assay |
|
|
Inhibition of human DK-MG cell growth in a cell viability assay, IC50 = 6.44516 μM. |
SANGER |
NCI-H1693 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1693 cell growth in a cell viability assay, IC50 = 7.89571 μM. |
SANGER |
JVM-2 |
Growth inhibition assay |
|
|
Inhibition of human JVM-2 cell growth in a cell viability assay, IC50 = 8.39779 μM. |
SANGER |
MSTO-211H |
Growth inhibition assay |
|
|
Inhibition of human MSTO-211H cell growth in a cell viability assay, IC50 = 8.80042 μM. |
SANGER |
UACC-812 |
Growth inhibition assay |
|
|
Inhibition of human UACC-812 cell growth in a cell viability assay, IC50 = 8.91355 μM. |
SANGER |
CW-2 |
Growth inhibition assay |
|
|
Inhibition of human CW-2 cell growth in a cell viability assay, IC50 = 9.32494 μM. |
SANGER |
NCI-H1155 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1155 cell growth in a cell viability assay, IC50 = 9.63085 μM. |
SANGER |
NCI-H720 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H720 cell growth in a cell viability assay, IC50 = 10.9542 μM. |
SANGER |
P31-FUJ |
Growth inhibition assay |
|
|
Inhibition of human P31-FUJ cell growth in a cell viability assay, IC50 = 11.3858 μM. |
SANGER |
TALL-1 |
Growth inhibition assay |
|
|
Inhibition of human TALL-1 cell growth in a cell viability assay, IC50 = 11.8714 μM. |
SANGER |
NCI-H1838 |
Growth inhibition assay |
|
|
Inhibition of human NCI-H1838 cell growth in a cell viability assay, IC50 = 12.2348 μM. |
SANGER |